tag:blogger.com,1999:blog-93565522024-02-19T05:58:06.105+02:00European Hospital Pharmacy BlogThe Meeting Point for the European Hospital Pharmaciststzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comBlogger290125tag:blogger.com,1999:blog-9356552.post-51544449299198944642019-12-26T22:22:00.000+02:002019-12-27T09:59:04.358+02:00The End of the Road, the Last Post <div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://1.bp.blogspot.com/-wI1MXihxf5o/UDit-QnfxmI/AAAAAAAADhM/bayGuFqe-pAqmz1wIIsPMs-zvMfb8HZMwCPcBGAYYCw/s1600/nosfar_logo.JPG" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="141" data-original-width="143" src="https://1.bp.blogspot.com/-wI1MXihxf5o/UDit-QnfxmI/AAAAAAAADhM/bayGuFqe-pAqmz1wIIsPMs-zvMfb8HZMwCPcBGAYYCw/s1600/nosfar_logo.JPG" /></a></div>
<span style="-webkit-text-size-adjust: auto; font-size: 17.94px;"></span><br />
<div class="separator" style="clear: both; text-align: center;">
</div>
<span style="font-size: 17.94px;">Dear friends, the title of this post says it all: this is the end of the road for me as a pharmacist blogger.</span><br />
<div class="p2" style="-webkit-text-size-adjust: auto; font-size: 17.9px; font-stretch: normal; line-height: normal; min-height: 21.4px;">
<span class="s1" style="font-size: 17.94px;"></span><br /></div>
<div class="p1" style="-webkit-text-size-adjust: auto; font-size: 17.9px; font-stretch: normal; line-height: normal;">
<span class="s1" style="font-size: 17.94px;">Whether you’ve been following for one year or ten years, thank you so much for your support. You have made this whole journey worthwhile. </span></div>
<div class="p1" style="-webkit-text-size-adjust: auto; font-size: 17.9px; font-stretch: normal; line-height: normal;">
<span class="s1" style="font-size: 17.94px;"><br /></span></div>
<div class="p1" style="-webkit-text-size-adjust: auto; font-size: 17.9px; font-stretch: normal; line-height: normal;">
<span class="s1" style="font-size: 17.94px;">Thank you!!!</span><br />
<span class="s1" style="font-size: 17.94px;"><br /></span>
<span class="s1" style="font-size: 17.94px;">Leonidas</span></div>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-68917160520157847572019-05-29T20:18:00.000+03:002019-05-29T20:18:04.733+03:00Procurement, tendering and decision making processes in the hospital setting<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYu3TV43naGKE99A9NktPczftCRx_a8ZpF2LoMl9R_Ts9PHmTrdcU8qeUYamVekiXOoxRXYMJnN1XcufyEKjmTBLQpCQk9sdgnS_TT4ZdO4PHT71ttzYdFv42-_CtOiZTiJF96UA/s1600/eahp.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="156" data-original-width="203" height="153" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgYu3TV43naGKE99A9NktPczftCRx_a8ZpF2LoMl9R_Ts9PHmTrdcU8qeUYamVekiXOoxRXYMJnN1XcufyEKjmTBLQpCQk9sdgnS_TT4ZdO4PHT71ttzYdFv42-_CtOiZTiJF96UA/s200/eahp.png" width="200" /></a></div>
<br />
Through recent years, numerous innovative and exiting drug treatments have become available for treatment at hospitals to the benefit of patients. However, health budgets throughout Europe are challenged by the high costs of these drugs, and hospital pharmacies have a key role by buying medications for hospitals. In order to address the increasing medication costs, procurement and tendering should be considered as topics related to managing medication costs.<br />
<br />
Procurement can be performed at national, regional as well as at local hospital level. Pros and cons for the hospital pharmacies exist for performing procurement at the various levels including effects on drug cost reduction, continuity of drug supply, competition etc.<br />
<br />
Tenders are made when procuring drugs at hospital pharmacies, and various pros and cons exist for doing tenders as well. The traditional of doing tenders based on price only is widely accepted, however, value-based tenders including other aspects of the drugs than the price itself (e.g. patient safety issues, environmental aspects, quality-based factors and innovative characteristics) is becoming increasingly popular.<br />
<br />
The hospital pharmacist has a role for the future in ensuring relevance of the included factors of these value-based procurements.
In some European countries pay-per-performance and other models are used as a part of the tenders. These models may allow for the possibility of a greater price reduction, but they also lead to increased administration costs of monitoring of the tender and ensuring reimbursement.
Finally, procurement is regulated by EU-legislation, and all of the above should comply with these rules.<br />
<br />
<b>Learning objectives </b><br />
<br />
At the end of this synergy masterclass, participants will be able to: <br />
<ul style="text-align: left;">
<li>recall important EU-legislation with regard to procurement; </li>
<li>recognise pros and cons by doing procurement and tenders at national, regional and hospital level, respectively; </li>
<li>list elements of value-based procurement </li>
</ul>
<br />
<b>Source</b><br />
<br />
<a href="http://www.eahp.eu/synergy-masterclass/events/procurement" target="_blank">http://www.eahp.eu/synergy-masterclass/events/procurement</a> <br />
<br /></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-7280752062595339202018-11-13T08:13:00.001+02:002018-11-13T08:30:02.102+02:00EAHP's 2018 Survey on Medicines Shortages<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.eahp.eu/practice-and-policy/medicines-shortages/2018-medicines-shortage-survey" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" data-original-height="362" data-original-width="380" height="190" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgRSHtTxu7vEHc4rSfdHhgakchTZ2w45gdIBXcawzrNbhhWAeCBsQjKcEr-RrDV6kwmY6REBnuOXsMMXMPVr8t-38sPSNfmAwgSuvM1x34gONM6uSedQKTMG_8A3kU_dJxIIUkMwQ/s200/EAHP+Survey+logo9_0.jpg" width="200" /></a></div>
<br />
<div style="text-align: justify;">
On 7 November 2018, <a href="http://www.eahp.eu/" target="_blank"><b>EAHP</b></a> released the
results of its <b><a href="http://www.eahp.eu/practice-and-policy/medicines-shortages/2018-medicines-shortage-survey" target="_blank">2018 Medicines Shortages Survey</a></b>. The launch event of the
report summarising the findings from the largest pan-Europe survey on
medicines supply shortages took place at the Press Club in Brussels.</div>
<div style="text-align: justify;">
The <b><a href="http://www.eahp.eu/practice-and-policy/medicines-shortages/2018-medicines-shortage-survey" target="_blank">results of the 2018 Medicines Shortages Survey</a></b> underline that medicines shortages remain a major
problem for patients in European hospitals. In a number of ways the
issues have become more troublesome since the publication of EAHP’s last
survey results in 2014. In particular the percentage of hospital
pharmacists reporting shortages to be an issue in terms of delivering
the best care to patients has seen a significant increase with <b>91.8%
respondents, compared to 86.2% in 2014, stressing that medicines
shortages are a problem faced in their hospital pharmacy</b>.</div>
<div style="text-align: justify;">
Many hospital pharmacists highlighted
the need for more timely and accurate information on medicines
shortages. EAHP is consequently calling on all supply chain actors, the
European Commission and national governments to help improve the
collection of information about medicines shortages in Europe. Only a
comprehensive communication strategy on shortages targeting all European
states will ensure that all supply chain actors, including hospital
pharmacists, receive adequate information on the shortage of medicines
in their countries.<br />
<span style="color: white;">... </span></div>
<div style="text-align: justify;">
</div>
<h3 style="text-align: justify;">
Results from the 2018 Medicines Shortages Survey</h3>
<h3 style="text-align: justify;">
<span style="background-color: white;"><span style="color: white;">...</span> </span></h3>
<h3 style="text-align: justify;">
</h3>
<div style="text-align: justify;">
The report is available <b><a href="http://www.eahp.eu/sites/default/files/report_medicines_shortages2018.pdf">HERE</a></b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
The information of the report is also summarised for: <br />
<ul>
<li><b>patients</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/patients_eahp_2018_medicines_shortages_survey.pdf">HERE</a>), </li>
<li><b>other healthcare professionals</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/other_healthcare_professionals_eahp_2018_medicines_shortages_survey.pdf">HERE</a>),</li>
<li><b>hospital managers</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/hospital_managers_eahp_2018_medicines_shortages_survey.pdf">HERE</a>), </li>
<li><b>government officials</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/government_officials_eahp_2018_medicines_shortages_survey.pdf">HERE</a>) and </li>
<li><b>industry</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/industry_eahp_2018_medicines_shortages_survey.pdf">HERE</a>).</li>
</ul>
</div>
<div style="text-align: justify;">
<ul>
</ul>
Country specific information was prepared for: <ul>
<li><b>France</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/france_medicinesshortages.pdf">HERE</a>), </li>
<li><b>Germany</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/germany_medicinesshortages.pdf">HERE</a>), </li>
<li><b>Italy</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/italy_medicinesshortages.pdf">HERE</a>), </li>
<li><b>Spain</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/spain_medicinesshortages.pdf">HERE</a>) and the </li>
<li><b>United Kingdom</b> (leaflet is available <a href="http://www.eahp.eu/sites/default/files/uk_medicinesshortages.pdf">HERE</a>).</li>
</ul>
<br />
<ul>
</ul>
</div>
<div style="text-align: justify;">
</div>
<div style="text-align: justify;">
<b>Source</b></div>
<div style="text-align: justify;">
<br /></div>
<div style="text-align: justify;">
<a href="http://www.eahp.eu/practice-and-policy/medicines-shortages/2018-medicines-shortage-survey">http://www.eahp.eu/practice-and-policy/medicines-shortages/2018-medicines-shortage-survey</a> </div>
<div style="text-align: justify;">
<br /></div>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-44414316368764377922017-09-17T20:45:00.000+03:002018-11-13T08:39:08.353+02:00Medicines Shortages - European Commission eCOST Research Network - Action CA15105<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.cost.eu/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="65" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEidxpOf_E6qnahEGiqrQSTH40_SmXJmiyooF-PKCdqsoXFI9xuXQ75arohEctLM0bY8sB5XEWQbATlo1ZA0dKcrvZ7zvJXiA5YCrpKkkA_5qUFx5AWoSaz8wkGyDWh7z4n2cgNkWg/s320/logo_cost.png" width="320" /></a></div>
<br />
<b><a href="http://www.cost.eu/" target="_blank">eCOST</a></b> (<b>European Cooperation in Science and Technology</b>) is the longest-running European framework supporting trans-national cooperation among researchers, engineers and scholars across Europe.<br />
<br />
<b>European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages) </b><br />
<br />
The problems created by supply shortages of medicines have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. The cited causes are multifaceted ranging from production disruptions, natural disasters, discontinuations as well as difficulties created by various legal, trade and pricing frameworks.
Healthcare professionals require access to reliable and up-to-date information about the unavailability of a medicine in order that they can treat the patient in the best way possible. The significant patient impact because of the lack of medication, in terms of safety and management of their condition, will be researched. In addition the forced substitution to an alternative product or requirement to produce a medicine may increase the risk of error, stress and overall cost to the healthcare system.
According to the largest pan-European survey of healthcare professionals yet conducted on the topic, the products mainly affected in the European hospital sector are antimicrobials and oncology products used for large populations.
This Action will encourage systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional products. The Action aims to respond to clinical, financial and quality of life interests, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices.
<br />
<br />
<br />
<a name='more'></a><br />
<br />
It is a unique means for them to jointly develop their own ideas and new initiatives across all fields in science and technology, including social sciences and humanities, through pan-European networking of nationally funded research activities. Based on a European intergovernmental framework for cooperation in science and technology, COST has been contributing - since its creation in 1971 - to closing the gap between science, policy makers and society throughout Europe and beyond. As a precursor of advanced multidisciplinary research, COST plays a very important role in building a <b><a href="http://ec.europa.eu/research/era/index_en.html" target="_blank">European Research Area </a></b>(ERA).<br />
<br />
It anticipates and complements the activities of the EU Framework Programmes, constituting a “bridge” towards the scientific communities of COST Inclusiveness Target Countries. It also increases the mobility of researchers across Europe and fosters the establishment of scientific excellence.The problems created by supply<b> shortages of medicines</b> have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. The cited causes are <b>multifaceted ranging from production disruptions, natural disasters, discontinuations</b> as well as difficulties created by various legal, trade and pricing frameworks.<br />
<br />
<b>Healthcare professionals</b> require access to reliable and up-to-date information about the unavailability of a medicine in order that they can treat the patient in the best way possible. The <b>significant patient impact</b> because of the lack of medication, in terms of safety and management of their condition, will be researched. In addition the forced <b>substitution to an alternative product or requirement to produce a medicine </b>may increase the <b>risk of error, stress and overall cost to the healthcare system</b>.
According to the largest pan-European survey of healthcare professionals yet conducted on the topic, <b>the products mainly affected in the European hospital sector are antimicrobials and oncology products</b> used for large populations.<br />
<br />
<br />
This Action will encourage <b>systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional product</b>s. The Action aims to respond to clinical, financial and quality of life interests, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices.<br />
<br />
<br />
<b>Related links</b><br />
<a href="http://medicinesshortages.blogspot.com/" target="_blank"></a>
<br />
<ul style="text-align: left;">
</ul>
<a href="http://medicinesshortages.blogspot.com/" target="_blank">Medicines Shortages in Europe</a><br />
<br />
<div>
<a class="arrow neues-fenster" href="http://issuu.com/costprogramme/docs/cost_corporate_brochure" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">COST brochure on ISSU</span></a><a class="arrow neues-fenster" href="http://ec.europa.eu/programmes/horizon2020/en" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">Horizon 2020</span></a><a class="arrow neues-fenster" href="http://ec.europa.eu/programmes/horizon2020/en/h2020-section/future-and-emerging-technologies" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">FET - Future and Emerging Technologies </span></a><a class="arrow neues-fenster" href="http://ec.europa.eu/research/index.cfm?pg=why&lg=en" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">Why European Research?</span></a><a class="arrow neues-fenster" href="http://ec.europa.eu/research/era/index_en.htm" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" target="_blank" title="new browser window"><span style="font-family: inherit;">European Research Area (ERA)</span></a><a class="arrow neues-fenster" href="http://ec.europa.eu/research/index.cfm" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" title="new browser window"><span style="font-family: inherit;">Research at the European Commission</span></a>
<br />
<div>
<b><span style="font-family: inherit;">Sources</span></b><br />
<br />
<a href="http://www.cost.eu/" target="_blank">COST network</a><br />
<br />
<a href="http://medicinesshortages.blogspot.com/" target="_blank">Medicines Shortages in Europe </a><br />
<a href="http://www.cost.eu/COST_Actions/ca/CA15105" target="_blank"><br /></a>
<a href="http://www.cost.eu/COST_Actions/ca/CA15105" target="_blank">http://www.cost.eu/COST_Actions/ca/CA15105 </a></div>
</div>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-68612375268176398492017-02-15T18:23:00.002+02:002017-02-15T18:26:30.571+02:00IHE Pharmacy (PHARM) Educational Article, Falsified Medicines Directive - Supply chain interoperability in support of safer medication usage<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://ihe.net/uploadedFiles/Documents/Pharmacy/IHE%20Pharmacy%20FMD%20Guide_Rev1.0_2017-02-08.pdf" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="320" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEjv_1nphCXdSwn30_56lwsY2KKCTe4AmB18f3CIUBIKsT7t9VAMNRjPUWrZhwzwNzNu-51565yDTDD6ioN7mhFOhNPbdFKOjEvGGDWsGZkCQdvSF4u2vw7fPqHKPX7JF1ICW9pF0A/s320/IHE.jpeg" width="249" /></a></div>
<br />
This document is an initiative of <b><a href="http://www.ihe.net/Pharmacy/" target="_blank">IHE Pharmacy</a></b> to describe how interoperability can support the effort against falsified medicines, as laid out in the <b><a href="http://ec.europa.eu/health//sites/health/files/files/eudralex/vol-1/reg_2016_161/reg_2016_161_en.pdf" target="_blank">Falsified Medicines Directive - EU Regulation 2016/161</a></b>.<br />
<br />
<b><a href="http://www.ihe.net/" target="_blank">IHE</a></b> provides a standard interoperability architecture for the supply of healthcare products. This effort covers traceability, barcode scanning, message exchange, etc. All of these matters help monitor the supply chain and thus support the enforcement of the Falsified Medicines Directive.<br />
<br />
This paper explains that the requirements of the Falsified Medicines Directive constitute in identifying the medicinal products along the supply chain, and reporting that to a central data hub. <b>Using publicly available message structures helps software solution providers benefit of IHE’s testing opportunities and support a truly interoperable tracking mechanism.</b><br />
<br />
Scanning the products poses an operational challenge for users: even for easy barcode scanning, for normal volumes it becomes burdensome. In a medium hospital, the effort of identifying all the received primary packages upon reception would exceed one dedicated professional. For this, it is essential to use <b>standardized AIDC (Automatic Identification and Data Capture) technologies: standard media (e.g. Datamatrix barcodes) and standardized content.</b><br />
<br />
Standardized interoperability mechanisms also play a role in this: By providing <b>a standard electronic shipment list,</b> the supplier can inform about the content and unique identification numbers included in each shipped carton so that the users may scan the outside package, and the contents of the package are automatically filled into the necessary systems.<br />
<br />
<b>This document explains how these mechanisms - reporting and shipment content - can enable proper tracing of medicinal products, and when standardized they enable the different actors to do so with reduced effort</b>.<br />
<br />
<b>Sources</b><br />
<br />
<a href="http://www.ihe.net/" target="_blank">http://www.ihe.net/</a><br />
<a href="https://www.ihe-europe.net/" target="_blank">https://www.ihe-europe.net/ </a><br />
<a href="http://www.ihe.net/Pharmacy/" target="_blank">http://www.ihe.net/Pharmacy/</a><br />
<a href="http://ihe.net/uploadedFiles/Documents/Pharmacy/IHE%20Pharmacy%20FMD%20Guide_Rev1.0_2017-02-08.pdf" target="_blank">http://ihe.net/uploadedFiles/Documents/Pharmacy/IHE%20Pharmacy%20FMD%20Guide_Rev1.0_2017-02-08.pdf</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-91500719949799312962016-07-10T11:01:00.002+03:002016-07-10T11:02:55.312+03:00eHealth Forum: Catalyst for Reform – Enabler for Growth<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.ehealthforum.org/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="70" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgcnZDa_vMIcTI4iv9cl4z5b6xSS718396uh6J-AW2opCFiijdVZmGjWMQBz_YnD_BfFZkR8Fij8tIQnUKE5ZsA0pn1bfjMMi_EEBVHezALVGyW6_QNpvT_NOK0mm2qURfTLSHg_A/s200/eHealth.jpg" width="200" /></a></div>
<br />
The <b><a href="http://www.ehealthforum.org/" target="_blank">eHealth Forum</a></b> will be held in <b>Athens, Greece on the 25th and 26th of October, 2016</b> at the Megaron Athens International Conference Centre.<br />
<br />
The <a href="http://www.ehealthforum.org/" target="_blank">eHealth Forum</a> becomes the annual meeting point for Greece, the South East Mediterranean and the Middle East, to reach and network with key stakeholders.
The <b><a href="http://www.ehealthforum.org/" target="_blank">eHealth Forum</a></b> invites policy makers, industry leaders, medical professionals, health care providers, tech innovators, researchers, investors, pharma, telecommunications companies, patient advocacy groups and major health IT players to connect and pursue the role of ehealth as a catalyst of reform and enabler of economic growth.<br />
<br />
The rapidly growing eHealth sector estimated to dominate all areas of industry by 2020 presents a unique opportunity for collaboration, financial and scientific growth and social reform. Within this expanding market further developing information technologies and applications in digital health is essential to promote the reform of the healthcare system and therefore act as a catalyst for these imperative changes.
The process of reforming healthcare is, in and of itself, an enabler for economic growth in various sectors: research, industry, information and telecommunications technologies. The <b><a href="http://www.ehealthforum.org/" target="_blank">eHealth Forum</a></b> presents “hot” topics high on the “<b>digital agenda</b>” in Europe and the surrounding region, while providing the channel to present and disseminate information on scientific and technological advancements in healthcare.<br />
<br />
<b>Themes </b><br />
1. eHealth Framework<br />
2. eHealth in practice today<br />
3. Clinical management of chronic illness<br />
4. Patient at the centre: Health Applications<br />
5. Data-aware medical devices<br />
6. Big Data<br />
7. Cyber-security<br />
8. Behavioural Change
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<iframe allowfullscreen="" class="YOUTUBE-iframe-video" data-thumbnail-src="https://i.ytimg.com/vi/ZK5urxsJLC8/0.jpg" frameborder="0" height="266" src="https://www.youtube.com/embed/ZK5urxsJLC8?feature=player_embedded" width="320"></iframe></div>
<br />
<b>Source</b><br />
<b><br /></b>
<a href="http://www.ehealthforum.org/" target="_blank">http://www.ehealthforum.org/</a><br />
<br /></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-41323790289800776622016-07-09T14:58:00.002+03:002016-07-09T14:59:43.400+03:00IHE Pharmacy Educational Webinar 2016<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.ihe.net/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="42" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi67nfumwOTRLyG_eGX6-lLQ1hC9C4ammMuIRzkGfFTB7UuGYcGUmcOVhALSZES9U1u3ILPz0W-iGMgTonKljBZb4URFZDILWfj-Ckw1RMNEYbbdO0zqlpUU9PwpIWv3_aQqSbvTQ/s200/ihe_logo.jpg" width="200" /></a></div>
<div style="border: 0px; color: #333333; font-family: Georgia, 'Bitstream Charter', serif; font-size: 16px; margin-bottom: 24px; padding: 0px; vertical-align: baseline;">
<a href="http://www.ihe.net/" style="border: 0px; color: #743399; margin: 0px; padding: 0px; vertical-align: baseline;" target="_blank">IHE (Integrating the Healthcare Enterprise) </a>annually presents a series of free educational <strong style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">webinars</strong> from June through September.</div>
<div style="border: 0px; color: #333333; font-family: Georgia, 'Bitstream Charter', serif; font-size: 16px; margin-bottom: 24px; padding: 0px; vertical-align: baseline;">
The series will help your organization learn about IHE; engage in IHE development and testing activities; and, leverage IHE solutions to develop and implement interoperable health IT systems.</div>
<div style="border: 0px; color: #333333; font-family: Georgia, 'Bitstream Charter', serif; font-size: 16px; margin-bottom: 24px; padding: 0px; vertical-align: baseline;">
<div class="separator" style="clear: both; text-align: center;">
<iframe allowfullscreen="" class="YOUTUBE-iframe-video" data-thumbnail-src="https://i.ytimg.com/vi/KK_G-n7f46g/0.jpg" frameborder="0" height="266" src="https://www.youtube.com/embed/KK_G-n7f46g?feature=player_embedded" width="320"></iframe></div>
<br /></div>
<div style="border: 0px; color: #333333; font-family: Georgia, 'Bitstream Charter', serif; font-size: 16px; margin-bottom: 24px; padding: 0px; vertical-align: baseline;">
<strong style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">Pharmacy webinar </strong>Learning Objectives:</div>
<ul style="border: 0px; color: #333333; font-family: Georgia, 'Bitstream Charter', serif; font-size: 16px; list-style: square; margin: 0px 0px 24px 1.5em; padding: 0px; vertical-align: baseline;">
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">Understand PHARM vision, mission and strategic goals.</li>
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">Understand PHARM domain’s liaison and collaboration with HL7 and ISO.</li>
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">Overview of existing PHARM profiles and Community and Hospital Pharmacy, including Community Medication Prescription and Dispense, Hospital Medication Workflow, Medication Treatment Plan</li>
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">Overview of other PHARM domain activities, including Supply Chain and FHIR</li>
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">Understand how PHARM work benefits the pharmacists.</li>
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">How to get involved in PHARM committee work.</li>
</ul>
<div>
<span style="color: #333333; font-family: "georgia" , "bitstream charter" , serif;">Download:</span></div>
<div>
<div style="text-align: left;">
</div>
<br />
<ul style="text-align: left;">
<li><a class="external text" href="ftp://ftp.ihe.net/Pharmacy/yr7_2015-2016/Planning_Committee/Webinar/Webinar_IHE_Pharmacy_2016.pptx" rel="nofollow" style="background-image: linear-gradient(transparent, transparent), url(data:image/svg+xml,%3C%3Fxml%20version%3D%221.0%22%20encoding%3D%22UTF-8%22%20standalone%3D%22no%22%3F%3E%0A%3Csvg%20xmlns%3Ardf%3D%22http%3A%2F%2Fwww.w3.org%2F1999%2F02%2F22-rdf-syntax-ns%23%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20height%3D%2213%22%20width%3D%2213%22%20version%3D%221.1%22%20xmlns%3Acc%3D%22http%3A%2F%2Fcreativecommons.org%2Fns%23%22%20xmlns%3Adc%3D%22http%3A%2F%2Fpurl.org%2Fdc%2Felements%2F1.1%2F%22%3E%0A%3Cg%20transform%3D%22translate%28-136.35715%2C-374.43362%29%22%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233465ba%3B%22%20d%3D%22m137.4%2C376.9%2C0%2C7.5%2C1-0.9872%2C0-6.013%2C2%2C0%2C2%2C1%2C4-0.0002%2C0%2C2%2C1%2C0%2C0-2.5-0.5-0.5002-4.5%2C0.0002-2-1-2.5%2C0z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%2316a4e8%3B%22%20d%3D%22m142.4%2C379.4-1-0.0001-2.5%2C0-0.5%2C0.5-1%2C4.5%2C10-0.0001%2C0-4.5-0.5-0.5zm0%2C1%2C4-0.0001%2C0%2C3-7.75-0.0001%2C0.75-3%2C2%2C0z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233465ba%3B%22%20d%3D%22m138.4%2C385.4%2C0%2C1%2C8%2C0%2C0-1z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233465ba%3B%22%20d%3D%22m141.4%2C383.9%2C0%2C2%2C2%2C0%2C0-2c0-0.5-2-0.5-2%2C0z%22%2F%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E%0A); background-position: 100% 50%, 100% 50%; background-repeat: no-repeat no-repeat; color: #663366; padding-right: 15px; text-decoration: none;">Slides PPTX file</a></li>
</ul>
<ul style="text-align: left;">
<li><a class="external text" href="ftp://ftp.ihe.net/Pharmacy/yr7_2015-2016/Planning_Committee/Webinar/Webinar_IHE_Pharmacy_2016.pdf" rel="nofollow" style="background-image: linear-gradient(transparent, transparent), url(data:image/svg+xml,%3C%3Fxml%20version%3D%221.0%22%20encoding%3D%22UTF-8%22%20standalone%3D%22no%22%3F%3E%0A%3Csvg%20xmlns%3Ardf%3D%22http%3A%2F%2Fwww.w3.org%2F1999%2F02%2F22-rdf-syntax-ns%23%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20height%3D%2213%22%20width%3D%2213%22%20version%3D%221.1%22%20xmlns%3Acc%3D%22http%3A%2F%2Fcreativecommons.org%2Fns%23%22%20xmlns%3Adc%3D%22http%3A%2F%2Fpurl.org%2Fdc%2Felements%2F1.1%2F%22%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%2315a5ea%3B%22%20d%3D%22m7.5%2C2%2C0%2C3%2C2.5%2C0%2C1-1-2.5%2C0%2C0-3z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233366bb%3B%22%20d%3D%22m3%2C1%2C0%2C10%2C8%2C0%2C0-7-2.5-3zm1%2C1%2C4%2C0%2C2%2C2.5%2C0%2C5.5-6%2C0z%22%2F%3E%0A%3C%2Fsvg%3E%0A); background-position: 100% 50%, 100% 50%; background-repeat: no-repeat no-repeat; color: #663366; padding-right: 15px; text-decoration: none;">Slides PDF file</a></li>
</ul>
<ul style="text-align: left;">
<li><a class="external text" href="ftp://ftp.ihe.net/Pharmacy/yr7_2015-2016/Planning_Committee/Webinar/IHE-Pharmacy-Domain-Update-2016.mp4" rel="nofollow" style="background-image: linear-gradient(transparent, transparent), url(data:image/svg+xml,%3C%3Fxml%20version%3D%221.0%22%20encoding%3D%22UTF-8%22%20standalone%3D%22no%22%3F%3E%0A%3Csvg%20xmlns%3Ardf%3D%22http%3A%2F%2Fwww.w3.org%2F1999%2F02%2F22-rdf-syntax-ns%23%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20height%3D%2213%22%20width%3D%2213%22%20version%3D%221.1%22%20xmlns%3Acc%3D%22http%3A%2F%2Fcreativecommons.org%2Fns%23%22%20xmlns%3Adc%3D%22http%3A%2F%2Fpurl.org%2Fdc%2Felements%2F1.1%2F%22%3E%0A%3Cg%20transform%3D%22translate%28-136.35715%2C-374.43362%29%22%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233465ba%3B%22%20d%3D%22m137.4%2C376.9%2C0%2C7.5%2C1-0.9872%2C0-6.013%2C2%2C0%2C2%2C1%2C4-0.0002%2C0%2C2%2C1%2C0%2C0-2.5-0.5-0.5002-4.5%2C0.0002-2-1-2.5%2C0z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%2316a4e8%3B%22%20d%3D%22m142.4%2C379.4-1-0.0001-2.5%2C0-0.5%2C0.5-1%2C4.5%2C10-0.0001%2C0-4.5-0.5-0.5zm0%2C1%2C4-0.0001%2C0%2C3-7.75-0.0001%2C0.75-3%2C2%2C0z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233465ba%3B%22%20d%3D%22m138.4%2C385.4%2C0%2C1%2C8%2C0%2C0-1z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233465ba%3B%22%20d%3D%22m141.4%2C383.9%2C0%2C2%2C2%2C0%2C0-2c0-0.5-2-0.5-2%2C0z%22%2F%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E%0A); background-position: 100% 50%, 100% 50%; background-repeat: no-repeat no-repeat; color: #663366; padding-right: 15px; text-decoration: none;">Webinar MP4 file</a></li>
</ul>
<ul style="text-align: left;">
<li><a class="external text" href="https://www.youtube.com/watch?v=KK_G-n7f46g" rel="nofollow" style="background-image: linear-gradient(transparent, transparent), url(data:image/svg+xml,%3C%3Fxml%20version%3D%221.0%22%20encoding%3D%22UTF-8%22%20standalone%3D%22no%22%3F%3E%0A%3Csvg%20xmlns%3Ardf%3D%22http%3A%2F%2Fwww.w3.org%2F1999%2F02%2F22-rdf-syntax-ns%23%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20height%3D%2213%22%20width%3D%2213%22%20version%3D%221.1%22%20xmlns%3Acc%3D%22http%3A%2F%2Fcreativecommons.org%2Fns%23%22%20xmlns%3Adc%3D%22http%3A%2F%2Fpurl.org%2Fdc%2Felements%2F1.1%2F%22%3E%0A%3Cg%20transform%3D%22translate%28-36.467808%2C-258.39005%29%22%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233366bb%3B%22%20d%3D%22m41.47%2C259.4%2C7%2C0%2C0%2C7-2-2-3%2C2%2C0-1%2C3-2.25%2C1%2C1%2C0-3.75-3.75%2C0%2C1%2C1-2.25%2C3-1%2C0%2C2-3z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%233366bb%3B%22%20d%3D%22m43.47%2C261.4-5%2C0%2C0%2C8%2C8%2C0%2C0-5-1%2C0%2C0%2C4-6%2C0%2C0-6%2C4%2C0z%22%2F%3E%0A%3Cpath%20style%3D%22opacity%3A1%3Bfill%3A%2315a5ea%3B%22%20d%3D%22m40.55%2C263.9c0-0.6213%2C0.6213-0.6213%2C0.6213-0.6213%2C1.864%2C0.6213%2C3.107%2C1.864%2C3.728%2C3.728%2C0%2C0%2C0%2C0.6213-0.6213%2C0.6213-1.243-1.864-1.864-2.485-3.728-3.728z%22%2F%3E%0A%3C%2Fg%3E%0A%3C%2Fsvg%3E%0A); background-position: 100% 50%, 100% 50%; background-repeat: no-repeat no-repeat; color: #663366; padding-right: 15px; text-decoration: none;">Webinar on YouTube</a></li>
</ul>
<u style="border: 0px; color: #333333; font-family: georgia, 'bitstream charter', serif; font-size: 16px; margin: 0px; padding: 0px; vertical-align: baseline;">Sources :</u><br />
<u style="border: 0px; color: #333333; font-family: georgia, 'bitstream charter', serif; font-size: 16px; margin: 0px; padding: 0px; vertical-align: baseline;"><br /></u></div>
<ul style="border: 0px; color: #333333; font-family: Georgia, 'Bitstream Charter', serif; font-size: 16px; list-style: square; margin: 0px 0px 24px 1.5em; padding: 0px; vertical-align: baseline;">
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;"><a href="http://simonletellier.adiph.fr/2016/07/08/ihe-pharmacy-educational-webinar-2016/" target="_blank">http://simonletellier.adiph.fr/2016/07/08/ihe-pharmacy-educational-webinar-2016/</a></li>
<li style="border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;"><a href="http://wiki.ihe.net/index.php?title=Pharmacy_Planning_Committee#Webinars" style="border: 0px; color: #743399; margin: 0px; padding: 0px; vertical-align: baseline;" target="_blank">http://wiki.ihe.net/index.php?title=Pharmacy_Planning_Committee#Webinars</a></li>
</ul>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-88329421339537388032016-03-08T11:56:00.001+02:002016-03-08T11:56:37.660+02:00IHE (Integrating the Healthcare Enterprise) World Summit 2016<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYbgPjX-HHp_CdH1RPIZ-nlZWN9Ti9gb7p_NBEnrx6SYAKLx-DpUjR6kxhCruX_qqwmSdlDo9r4QZIatWpAk3ORdhyphenhyphen4_u89xsDQdaYlV1jS64hDxHOrUxjj7ykMAK5XshhnTwH5w/s1600/HIMSSeu_ehealth_week_IHE2016_banner_1200x100.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="32" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiYbgPjX-HHp_CdH1RPIZ-nlZWN9Ti9gb7p_NBEnrx6SYAKLx-DpUjR6kxhCruX_qqwmSdlDo9r4QZIatWpAk3ORdhyphenhyphen4_u89xsDQdaYlV1jS64hDxHOrUxjj7ykMAK5XshhnTwH5w/s400/HIMSSeu_ehealth_week_IHE2016_banner_1200x100.png" width="400" /></a></div>
<br />
<div style="background-color: white; font-family: arial; font-size: 14px; line-height: 1.5em; margin-bottom: 20px; margin-left: 20px;">
The <b><a href="http://www.ehealthweek.org/ehome/128630/ihe-world-summit/?&" target="_blank">IHE World Summit</a></b> will be held in parallel to <b><a href="http://www.ehealthweek.org/ehome/index.php?eventid=128630&" target="_blank">eHealth Week</a></b> <b>on 7 and 8 June 2016 in Amsterdam, The Netherlands</b>. </div>
<div style="background-color: white; font-family: arial; font-size: 14px; line-height: 1.5em; margin-bottom: 20px; margin-left: 20px;">
IHE brings together healthcare IT system users and developers to address interoperability issues that impact clinical care. The work involves identifying real-world scenarios/use cases, writing and reviewing specifications, implementing in products, monitoring vendor testing, etc. We invite you to become involved in one or more of these activities.</div>
<a href="https://www.blogger.com/null" name="about" style="background-color: white; font-family: arial; font-size: 14px;"></a><span style="background-color: white; font-family: "arial"; font-size: 14px;"></span><br />
<div style="background-color: white; font-family: arial; font-size: 14px; line-height: 1.5em; margin-bottom: 20px; margin-left: 20px;">
<b><a href="http://www.ihe.net/" target="_blank">IHE (Integrating the Healthcare Enterprise</a></b>) is an initiative by healthcare professionals and industry to improve the way computer systems in healthcare share information. </div>
<div style="background-color: white; font-family: arial; font-size: 14px; line-height: 1.5em; margin-bottom: 20px; margin-left: 20px;">
IHE promotes the coordinated use of established standards such as<b> DICOM and HL7</b> to address specific clinical needs in support of optimal patient care. </div>
<div style="background-color: white; font-family: arial; font-size: 14px; line-height: 1.5em; margin-bottom: 20px; margin-left: 20px;">
Systems developed in accordance with IHE communicate with one another better, are easier to implement, and enable care providers to use information more effectively.</div>
<br />
<b>Source</b><br />
<br />
<a href="http://www.ehealthweek.org/ehome/128630/ihe-world-summit/?&" target="_blank">IHE World Summit 2016</a><br />
<br /></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-49032384400091577782016-02-11T14:01:00.003+02:002016-02-11T14:30:56.240+02:00European Commission publishes the final text for the Falsified Medicines Directive Delegated Regulation<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhcyeysppDwSE3h1a_8ugfQKEu008CUlJFrLmbwlC7DI8RzPwDKcAMrfRRDUOe-WHsHmHMYpWAEYani_M86GKI3Dmnvy2ONufAD54TkwI6XpDUfSLGO5KhpZIg3Kr8FEF8fCvDz5A/s1600/logo_en.gif" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhcyeysppDwSE3h1a_8ugfQKEu008CUlJFrLmbwlC7DI8RzPwDKcAMrfRRDUOe-WHsHmHMYpWAEYani_M86GKI3Dmnvy2ONufAD54TkwI6XpDUfSLGO5KhpZIg3Kr8FEF8fCvDz5A/s1600/logo_en.gif" /></a></div>
<br />
The <b>European Commission</b> has published the long-awaited <b>Delegated Regulation</b>, setting out the requirements for the future <b>system of medicines verification</b> that must operate in all EU countries.<br />
<br />
<a href="http://ec.europa.eu/health/files/eudralex/vol-1/reg_2016_161/reg_2016_161_en.pdf" target="_blank">http://ec.europa.eu/health/files/eudralex/vol-1/reg_2016_161/reg_2016_161_en.pdf</a><br />
<br />
<b>COMMISSION DELEGATED REGULATION (EU) 2016/161 </b><br />
<b>of 2 October 2015 </b><br />
<b>supplementing Directive 2001/83/EC </b><br />
<b>of the European Parliament and of the Council </b><br />
<b>by laying down detailed rules for the safety features appearing on thpackaging of medicinal products for human use. </b><br />
<br />
<b>This Regulation lays down: </b><br />
(a) the characteristics and technical specifications of the unique identifier that enables the authenticity of medicinal products to be verified and individual packs to be identified;<br />
(b) the modalities for the verification of the safety features;<br />
(c) the provisions on the establishment, management and accessibility of the repositories system where the information on the safety features shall be contained;<br />
(d) the list of medicinal products and product categories subject to prescription which shall not bear the safety features;<br />
(e) the list of medicinal products and product categories not subject to prescription which shall bear the safety features;<br />
(f) the procedures for the notification to the Commission by national competent authorities of non-prescription medicinal products judged at risk of falsification and prescription medicinal products not deemed at risk of falsification in accordance with the criteria set out in Article 54a(2)(b) of Directive 2001/83/EC;<br />
(g) the procedures for a rapid evaluation of and decision on the notifications referred to in point (f) of this Article. L 32/6 EN Official Journal of the European Union 9.2.2016<br />
<br />
<br />
<a name='more'></a><br />
<br />
<b>Scope </b><br />
1. This Regulation applies to:<br />
(a) medicinal products subject to prescription which shall bear safety features on their packaging pursuant to Article 54a(1) of Directive 2001/83/EC, unless included in the list set out in Annex I to this Regulation;<br />
(b) medicinal products not subject to prescription included in the list set out in Annex II to this Regulation;<br />
(c) medicinal products to which Member States have extended the scope of application of the unique identifier or of the anti-tampering device in accordance with Article 54a(5) of Directive 2001/83/EC.
2. For the purposes of this Regulation, where reference is made to the packaging in a provision of this Regulation, the provision shall apply to outer packaging or to the immediate packaging if the medicinal product has no outer packaging.<br />
<br />
You can download the document from <b><a href="http://ec.europa.eu/health/files/eudralex/vol-1/reg_2016_161/reg_2016_161_en.pdf" target="_blank">HERE</a></b>.<br />
<b>Source</b><br />
<br />
<a href="http://ec.europa.eu/health/files/eudralex/vol-1/reg_2016_161/reg_2016_161_en.pdf" target="_blank">http://ec.europa.eu/health/files/eudralex/vol-1/reg_2016_161/reg_2016_161_en.pdf</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-74696502155911301562016-02-09T19:32:00.003+02:002016-02-09T19:32:47.551+02:00The European Medicines Verification Organisation (EMVO) signs framework agreements with service providers to establish blueprint systems<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhLlm-RgG0BS3pbAMnKpdVXG0KtHv9TWITcWtRKM6aPMAeLOA-58JIgYkGkzR6ij4sokRE86nfzV6SPYp_1MuG82Z-gQBcusj0PPHctV_dXvqAY0XQorEmsIyEfCJE6IZoqFaNVOw/s1600/efpia.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="77" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhLlm-RgG0BS3pbAMnKpdVXG0KtHv9TWITcWtRKM6aPMAeLOA-58JIgYkGkzR6ij4sokRE86nfzV6SPYp_1MuG82Z-gQBcusj0PPHctV_dXvqAY0XQorEmsIyEfCJE6IZoqFaNVOw/s200/efpia.jpg" width="200" /></a></div>
<br />
<div style="background: rgb(255, 255, 255); border: 0px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;"><span style="line-height: 21.6px;">The <b><a href="http://www.efpia.eu/" target="_blank">European Medicines Verification Organisation (EMVO)</a></b> is a Luxembourgish non-profit organisation representing stakeholders united in <b>securing the legal supply chain from falsified medicines</b>. </span></span></div>
<div style="background: rgb(255, 255, 255); border: 0px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;"><span style="line-height: 21.6px;">Its founding members are EFPIA, the European Federation of Pharmaceutical Industries and Associations, the EGA, the European Generic and Biosimilar medicines Association, PGEU, the Pharmaceutical Group of the European Union, GIRP, the European Association of Pharmaceutical Full-line Wholesalers and EAEPC, the European Association of Euro-Pharmaceutical Companies.</span></span></div>
<div style="background: rgb(255, 255, 255); border: 0px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="line-height: 21.6px;"><span style="font-family: inherit;">The stakeholder organisation EMVO last Friday finalised its contract negotiations with 3 partners that will be the preferred providers to implement the repositories system in compliance with the Falsified Medicines Directive. The 3 partners are: </span></span><span style="line-height: 21.6px;"><b><a href="http://aegate.com/en/" target="_blank">Aegate Holdings Limited</a></b>, <b><a href="https://it.arvato.com/en.html" target="_blank">Arvato Systems GmbH</a></b> and <b><a href="http://www.reply.eu/solidsoft-reply/en/" target="_blank">Solidsoft Reply</a></b>.</span></div>
<div style="background: rgb(255, 255, 255); border: 0px; line-height: 21.6px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;">The repositories system will allow the verification for authentication of medicines in Europe. For this purpose 5 European stakeholder associations (<b>EAEPC, EFPIA, EGA, GIRP and PGEU</b>) have established in February of this year a non-profit organisation EMVO that is taking the lead in the creation of this system.</span></div>
<div style="background: rgb(255, 255, 255); border: 0px; line-height: 21.6px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;"></span></div>
<a name='more'></a><br />
<div style="background: rgb(255, 255, 255); border: 0px; line-height: 21.6px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;">The EMVO has designed a model that ensures a practical and cost-effective implementation of these repositories to minimise the burden of national stakeholder organisation or NMVOs which eventually will be responsible for the establishment and management of the systems. This blueprint model includes a support plan or implementation package and a short list of preferred service providers.</span></div>
<div style="background: rgb(255, 255, 255); border: 0px; line-height: 21.6px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;">The EMVO is proud to announce that it concluded a fruitful negotiation with 3 valued partners: <b>Aegate Holdings Limited, Arvato Systems GmbH and Solidsoft Reply</b>. NMVOs will have the opportunity to select a service provider best suited to establish a repository system in their Member State.</span></div>
<div style="background: rgb(255, 255, 255); border: 0px; line-height: 21.6px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;">Through the engagement of the whole pharmaceutical supply chain and with the support of our new partners, the EMVO has taken a major step to secure the legitimate supply chain and to prevent falsified medicines from reaching patients. <b>EMVO Director General ad-interim Andreas Walter</b> said: “<i>The agreement with our new partners brings us a step forward in the fight against falsified medicines. We would like to encourage national stakeholders to take the example of EMVO, establish NMVOs, and sign up with one of our selected service providers</i>”.</span></div>
<div style="background: rgb(255, 255, 255); border: 0px; line-height: 21.6px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<b><span style="font-family: inherit;">Source</span></b></div>
<div style="background: rgb(255, 255, 255); border: 0px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<span style="color: #595856; font-family: Arial, sans-serif;"><span style="font-size: 12px; line-height: 21.6px;"><a href="http://www.efpia.eu/" target="_blank">http://www.efpia.eu/</a></span></span></div>
<div style="background: rgb(255, 255, 255); border: 0px; color: #595856; font-family: Arial, sans-serif; font-size: 12px; line-height: 21.6px; margin-bottom: 20px; outline: 0px; padding: 0px; vertical-align: baseline;">
<br /></div>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-46465870727708124562016-02-04T15:41:00.002+02:002016-02-04T15:41:51.325+02:00OpenMedicine drive towards tangible outcomes – a triple win for Europe<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiGzoglg1pBFx0sdFCcoB0tfxG6eSkM3IMS6oVXAlmcXXUBEG_HpUiuC1ONExEvl2CoL3cmY2Y_xTtWCqPYaRw-oKdzSZC3zLI6cLoG8v3VbFV7d_2wnw-Z2Kv2ZZduyR1VY64jdQ/s1600/openmedicine_tr_dark.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="24" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiGzoglg1pBFx0sdFCcoB0tfxG6eSkM3IMS6oVXAlmcXXUBEG_HpUiuC1ONExEvl2CoL3cmY2Y_xTtWCqPYaRw-oKdzSZC3zLI6cLoG8v3VbFV7d_2wnw-Z2Kv2ZZduyR1VY64jdQ/s200/openmedicine_tr_dark.png" width="200" /></a></div>
<br />
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
The openMedicine Expert Council met for its 2nd meeting on Jan. 21 to 22, 2016 at the <a href="http://www.cencenelec.eu/Pages/default.aspx" style="color: #659ee3; text-decoration: none;" target="_blank">CEN – CENELEC Management Centre</a> in Brussels, Belgium. It was very well attended by more than 30 experts from Europe and the USA. They represented <a href="http://ec.europa.eu/health/human-use/index_en.htm" style="color: #659ee3; text-decoration: none;" target="_blank">medicinal products</a>, <a href="http://www.swedish.org/blog/2012/05/why-standardization" style="color: #659ee3; text-decoration: none;" target="_blank">standardisation</a>, and <a href="http://www.ema.europa.eu/ema/" style="color: #659ee3; text-decoration: none;" target="_blank">regulatory bodies</a>, the <a href="http://ec.europa.eu/health/index_en.htm" style="color: #659ee3; text-decoration: none;" target="_blank">European Commission</a>, and the core project team.</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
Based on and guided by first year project results, the experts</div>
<ul style="font-family: Lato, sans-serif; font-size: 16px; list-style-image: url("../images/bullet_img.png"); padding-left: 40px;">
<li style="color: #4a4a4c; font-size: 0.8em; line-height: 1.5em;">intensely discussed critical issues and challenges brought forward both by council members and the openMedicine team</li>
<li style="color: #4a4a4c; font-size: 0.8em; line-height: 1.5em;">debated options for standards and their impact on <a href="http://www.epsos.eu/epsos-services/eprescription.html" style="color: #659ee3; text-decoration: none;" target="_blank">prescriptions</a>, their dispensation at community pharmacies in another country, <a href="http://www.epsos.eu/epsos-services/patient-summary.html" style="color: #659ee3; text-decoration: none;" target="_blank">patient summaries</a> and <a href="http://cedd.oep.hu/" style="color: #659ee3; text-decoration: none;" target="_blank">drug databases</a></li>
<li style="color: #4a4a4c; font-size: 0.8em; line-height: 1.5em;">contributed suggestions on providing ultimately a set of recommendations for EU member states as well as an implementation roadmap on how to assure the univocal cross border identification of medicines for human use wherever needed.</li>
</ul>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
</div>
<a name='more'></a><br /><br />
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
Enabling the delivery of safe and efficient <a href="http://europa.eu/rapid/press-release_MEMO-13-918_en.htm" style="color: #659ee3; text-decoration: none;" target="_blank">cross-border healthcare</a> is a policy priority of the European Union. The openMedicine project contributes to this by solving an urgent problem of portability of ePrescriptions across Europe. The main challenge is the univocal identification of medicinal products to be dispensed by a community pharmacist in case of a cross-border (e)Prescription and dispensation. The project also addresses the different regulations regarding <a href="http://www.wma.net/en/30publications/10policies/d13" style="color: #659ee3; text-decoration: none;" target="_blank">substitution</a> of a prescribed medicine at the point of dispensation, considering that a pharmacist has to comply to the respective national rules, which often differ from those in the country where the prescription was issued.</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
Expert discussions clearly identified that the project is producing concrete results which are poised to deliver a very tangible triple win for Europe – for its citizens, patients and clinical professionals, its regulatory agencies and pharmaceutical industry; as well as for member states’ healthcare systems:</div>
<ul style="font-family: Lato, sans-serif; font-size: 16px; list-style-image: url("../images/bullet_img.png"); list-style-type: circle; padding-left: 40px;">
<li style="color: #4a4a4c; font-size: 0.8em; line-height: 1.5em;">Clinical domain: The globally univocal identification of pharmaceutical and medicinal products will allow for easy and consistent recording and exchanging of information on medicines in electronic health records (EHRs), (e)Prescriptions, dispensation reports, patient summaries etc. This will positively impact on patient safety, e.g. by reducing adverse drug events, benefit physicians and nurses by streamlining clinical care, supporting researchers undertaking clinical studies.</li>
<li style="color: #4a4a4c; font-size: 0.8em; line-height: 1.5em;">Regulatory and medicinal products domain: Project work is undertaken and coordinated with the <a href="http://www.ema.europa.eu/" style="color: #659ee3; text-decoration: none;" target="_blank">European Medicines Agency</a> (EMA), national regulatory agencies, producers of drug dictionaries and others involved in the wider pharmaceutical field. They will benefit from more consistent and higher quality data on medicinal products, easer registration and authorisation processes, more reliable exchange of data.</li>
<li style="color: #4a4a4c; font-size: 0.8em; line-height: 1.5em;">Member states’ health systems: Finally, the concrete implementation and wide diffusion of the data model(s), identifying attributes and semantic coding of data elements proposed by openMedicine in cooperation with standards development organisations (SDOs) (https://en.wikipedia.org/wiki/Standards_organization) , regulatory agencies and representatives from national health systems will strongly support the safety and continuity of care within member states and across borders, particularly in application fields like ePrescriptions, patient summaries, dispensation reporting, or analysis of such data for public health purposes.</li>
</ul>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
As a next step, the project is preparing a trans-Atlantic meeting, together with the <a href="http://www.fda.gov/" style="color: #659ee3; text-decoration: none;" target="_blank">USA Federal Drug Agency</a> (FDA), at its premises in Washington, DC. It is expected that it will be attended also by representatives of regulatory agencies from other continents and <a href="http://www.who-umc.org/DynPage.aspx?id=97218&mn1=7347&mn2=7252" style="color: #659ee3; text-decoration: none;" target="_blank">WHO-UMC</a>. It is planned to undertake a first proof of concept to generate a<a href="https://www.hl7.org/documentcenter/public_temp_51461948-1C23-BA17-0C01DE1947C4D451/wg/medication/ISO%20IDMP%20-%20Logical%20model%20classification%20and%20identification%20of%20pharmaceutical%20and%20medicinal%20products.pdf" style="color: #659ee3; text-decoration: none;" target="_blank">globally univocal identification code for pharmaceutical products</a>. The next Expert Council Meeting is planned for October of this year in London at the European Medicines Agency (EMA).</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
<br /></div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
<a href="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert1_bfd1cb3a03.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img alt="" border="0" height="95" src="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert1_bfd1cb3a03.jpg" style="border: none;" title="" width="63" /></a><i>“It was a very encouraging meeting in Brussels, which demonstrated the excellent progress the team has made since the first expert council last June. It feels as if an important milestone has been reached, so the focus can move from “what is the answer” to “how do we prepare for implementation.”</i>Jeremy Thorp<br />Director of Business Architecture<br />Health and Social Care Information Centre, Department of Health, UK</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
<br /></div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px; text-align: right;">
<a href="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert2_cc84daa0ab.jpg" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="" border="0" height="79" src="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert2_cc84daa0ab.jpg" style="border: none;" title="" width="79" /></a><i>“It was excellent to see the progress that is being made in openMedicine towards supporting cross border prescribing, by using the developing IDMP database from the regulatory agencies as a high quality and coherent source of medicinal product information to patient care. National medicinal product terminologies will be able to support their own business needs and support cross border use cases by implementing in harmony with the firm foundations of IDMP, so that in the future “cross border medication management” will be an accepted reality, increasing safety and quality for patients.”</i>Julie M James<br />Blue Wave Informatics LLP<br />EXETER</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px; text-align: right;">
</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
<br /></div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
<a href="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert3_326d87104c.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img alt="" border="0" height="88" src="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert3_326d87104c.png" style="border: none;" title="" width="68" /></a><i>“As Convenor of ISO TC 215’s working group developing and maintaining the IDMP standards, I am enthusiastic about openMedicine’s progresses. These are going to show the right and sustainable direction for the identification of medicinal products in clinical settings, such as retail pharmacies, hospitals and nursing homes. IDMP impacts related standards for prescription, dispensation, etc. which in a couple of months from now will be made available to implementers. That global approach includes supply chain processes and is providing enhanced patient safety in Europe and in the world.”</i>Christian Hay<br />GS1 Global Office<br />Brussels</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
<br /></div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px; text-align: right;">
<a href="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert4_42b49a5d2d.png" imageanchor="1" style="clear: right; float: right; margin-bottom: 1em; margin-left: 1em;"><img alt="" border="0" height="78" src="http://www.open-medicine.eu/fileadmin/_processed_/csm_expert4_42b49a5d2d.png" style="border: none;" title="" width="58" /></a><i>“The Pharmacy HIT Collaborative is honored to participate in the openMedicine project. Over the years the US has worked hard to achieve a standard level of uniformity of prescribed products and we hope the US work can help the project reach a global consensus resulting in the electronic delivery of appropriate medicine. The openMedicine project’s focus on standardized prescription medication identification is the first step to standardized global clinical medication-related terms. Sharing standardized data across borders is essential component of safe health.”</i>Rachelle “Shelly” Spiro, RPh, FASCP<br />Pharmacy Health Information Technology Collaborative<br />Washington, DC, USA</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px; text-align: right;">
</div>
<div style="color: #4a4a4c; font-family: Lato, sans-serif; font-size: 0.8em; line-height: 1.5em; padding-left: 10px; padding-right: 10px;">
<br /></div>
<div>
<br /></div>
<br />
<b>Source</b><br />
<br />
<a href="http://www.open-medicine.eu/openmed/" target="_blank">http://www.open-medicine.eu/openmed/</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-54377731762219347672016-01-19T07:55:00.003+02:002016-01-19T07:57:22.925+02:00ECHI - European Core Health Indicators<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://ec.europa.eu/health/index_en.htm" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEipGDM3ihfZFzzUg0lUDbnrhsXar-RUthgUqYN2oBTkG-FdkVJVzJU0Kmvlwjd8LzYuLHa61YytuOn9YbJg71Qw9t-oH4nvJxe4O6ScTkqlBPPugdPNH9O3Rs7CANbsic8VBHiRsg/s1600/Public_health.gif" /></a></div>
<br />
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin-bottom: 1em; outline: none; padding: 0px; text-align: justify;">
The <b><a href="http://ec.europa.eu/health/indicators/echi/index_en.htm" target="_blank">European Core Health Indicators (ECHI)</a></b>, formerly known as European Community Health Indicators are the result of a long-term cooperation between the <b>EU Member States and the European Commission</b>. Three <b><a href="http://ec.europa.eu/health/indicators/echi/index_en.htm" target="_blank">ECHI projects</a></b> (1998-2001, 2001-2004, 2005-2008) funded under the EU Health Programmes established the first lists of ECHI indicators, aiming to create a comparable health information and knowledge system to monitor health at EU level.</div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin-bottom: 1em; outline: none; padding: 0px; text-align: justify;">
Under the <a href="http://ec.europa.eu/health/programme/policy/2008-2013/index_en.htm" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;">Second Programme of Community Action in the Field of Health 2008-2013</a>, the EU funded the <a href="http://www.echim.org/" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Joint Action (JA) on European Community Health Indicators Monitoring (ECHIM)</a>. The JA ECHIM built on previous achievements and developed more precise definitions of the indicators and continued the implementation of the indicators in the Member States. One of the aims of the ECHIM was to consolidate and expand the ECHI indicator system towards a sustainable health monitoring system in Europe supporting the <a class="link-ico" href="http://ec.europa.eu/health-eu/doc/whitepaper_en.pdf" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">EU Health Strategy<img alt="pdf" border="0" src="http://ec.europa.eu/wel/images/doc_icons/f_pdf_16.gif" style="border-radius: 0px !important; border: 0px; clear: none !important; float: none !important; font-family: inherit; font-style: inherit; margin: 0px !important; outline: none; padding: 0px 0px 0px 4px; vertical-align: middle;" /></a>. The work was carried out in close collaboration with Member States, the European Commission, Eurostat, WHO, OECD and other international organisations. The JA ended in June 2012 and the main result was a shortlist of <a class="link-ico" href="http://ec.europa.eu/health/indicators/docs/echi_shortlist_by_policy_area_en.pdf" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">88 health indicators<img alt="pdf" border="0" src="http://ec.europa.eu/wel/images/doc_icons/f_pdf_16.gif" style="border-radius: 0px !important; border: 0px; clear: none !important; float: none !important; font-family: inherit; font-style: inherit; margin: 0px !important; outline: none; padding: 0px 0px 0px 4px; vertical-align: middle;" /><span class="link-size" style="border: 0px; color: #333333; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px 0px 0px 4px;">(248 KB)</span></a>classified by policy areas.</div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin-bottom: 1em; outline: none; padding: 0px; text-align: justify;">
In May 2013, the <a href="http://ec.europa.eu/health/strategy/implementation/hic/index_en.htm" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;">Expert Group on Health Information</a> agreed to rename the ECHI to European <strong style="border: 0px; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px;">Core</strong> Health Indicators.</div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin-bottom: 1em; outline: none; padding: 0px; text-align: justify;">
Definitions and data collection are in place for nearly 60 out of 88 ECHI indicators. The indicators under development still need further refinement before being accessible in the ECHI data tool. ECHI indicators are grouped below under five main chapters. To access data and metadata, click on the indicator to go to the ECHI data tool. This tool allows presenting selected indicators in different layouts: line chart, bar chart, map or table.<br />
<br />
<a name='more'></a><br /></div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin-bottom: 1em; outline: none; padding: 0px; text-align: justify;">
Indicators are at the crossroads of policy questions and data sets. They reflect a policy interest as well as a selected set of possibilities in terms of what can be calculated. For these reasons, the European Commission also presents other European health indicators that are not part of the ECHI system but are still useful to health stakeholders (see below). Intended indicators below are also directly accessible through the <a href="http://ec.europa.eu/health/indicators/indicators/index_en.htm" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">ECHI data tool</a>.</div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin-bottom: 1em; outline: none; padding: 0px; text-align: justify;">
Where considered useful or appropriate, stratification by gender and age is applied. Breakdowns by socio-economic or regional level are provided when available.</div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
<a href="https://www.blogger.com/null" name="id1" style="border: 0px; color: #027ac6; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: underline;"></a></div>
<h3 style="background: url("/health/images/informative/arrow.gif") 0px 3px no-repeat rgb(255, 255, 255); border: 0px; color: #0065a2; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 1.4em; line-height: 1.1em; margin: 18px 0px 6px; outline: none; padding: 0px 0px 0px 15px; text-align: justify;">
Demography and socio-economic situation</h3>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
1. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=1a,1b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Population by sex / age - Old-age-dependency ratio (I)</a><br />
2. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=2" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Birth rate, crude (I)</a><br />
3. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=3" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Mother's age distribution (I)</a><br />
4. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=4" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Total fertility rate (I)</a><br />
5. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=5" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Population projections (I)</a><br />
6. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=6" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Population by education (I)</a><br />
7. Population by occupation (D)<br />
8. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=8" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Total unemployment (I)</a><br />
9(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=9a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Population below poverty line (I)</a></div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
9(b). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=9b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Income inequality (I)</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
<a href="https://www.blogger.com/null" name="id2" style="border: 0px; color: #027ac6; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: underline;"></a></div>
<h3 style="background: url("/health/images/informative/arrow.gif") 0px 3px no-repeat rgb(255, 255, 255); border: 0px; color: #0065a2; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 1.4em; line-height: 1.1em; margin: 18px 0px 6px; outline: none; padding: 0px 0px 0px 15px; text-align: justify;">
Health status</h3>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
10. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=10a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Life expectancy (I)</a></div>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
<a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=10b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Life expectancy by educational attainment (I)</a><br />
11. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=11" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Infant mortality (I)</a><br />
12. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=12" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Perinatal mortality (I) </a><br />
13. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=13" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Disease-specific mortality (I)</a><br />
14. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=14" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Drug-related deaths (I)</a><br />
15. Smoking-related deaths (D)<br />
16. Alcohol-related deaths (D)<br />
17. Excess mortality by heat waves (D)<br />
18. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=18" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Selected communicable diseases (I)</a><br />
19. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=2" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">HIV/AIDS (I)</a><br />
20. Cancer incidence (D)<br />
21(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=21a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Diabetes: self-reported prevalence (I)</a>21(b). Diabetes: register-based prevalence (D)<br />
22. Dementia (D)<br />
<img alt="euhi" src="http://ec.europa.eu/health/indicators/pics/euhi.jpg" height="26" style="border: 0px; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px;" title="euhi" width="85" /><a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=22" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">European health indicator on dementia</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
23(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=23a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Depression: self-reported prevalence (I)</a><br />
23(b). Depression: register-based prevalence (D)<br />
24. Acute myocardial infarction (AMI) (D)<br />
25. Stroke (D)<br />
26(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=26a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Asthma: self-reported prevalence (I)</a><br />
26(b). Asthma: register-based prevalence (D)<br />
27(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=27a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Chronic obstructive pulmonary disease (COPD): self-reported prevalence (I)</a><br />
27(b). Chronic obstructive pulmonary disease (COPD): register-based prevalence (D)<br />
28. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=28" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Low birth weight (I)</a><br />
29(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=29a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Injuries: home, leisure, school: self-reported incidence (I)</a><br />
29(b). Injuries: home, leisure, school: register-based incidence (D)<br />
30(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=30a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Injuries: road traffic: self-reported incidence (I)</a><br />
30(b). Injuries: road traffic: register-based incidence (D)<br />
31. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=31" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Injuries: workplace (I)</a><br />
32. Suicide attempt (D)<br />
33. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=33" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Self-perceived health (I)</a><br />
34. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=34" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Self-reported chronic morbidity (I)</a><br />
35. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=35" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Long-term activity limitations (I)</a><br />
36. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=36" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Physical and sensory functional limitations (I)</a><br />
37. General musculoskeletal pain (D)<br />
38. Psychological distress (D)<br />
39. Psychological well-being (D)<br />
40(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=40a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Health expectancy: Healthy Life Years (HLY) (I) - 2004 onwards</a><br />
40(b). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=40b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Health expectancy: Healthy Life Years (HLY) (I) - before 2004</a><br />
41. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=41" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Health expectancy, others (I)</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
<a href="https://www.blogger.com/null" name="id3" style="border: 0px; color: #027ac6; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: underline;"></a></div>
<h3 style="background: url("/health/images/informative/arrow.gif") 0px 3px no-repeat rgb(255, 255, 255); border: 0px; color: #0065a2; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 1.4em; line-height: 1.1em; margin: 18px 0px 6px; outline: none; padding: 0px 0px 0px 15px; text-align: justify;">
Determinants of health</h3>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
42. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=42" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Body mass index (I)</a><br />
43. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=43" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Blood pressure (I)</a><br />
44. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=44" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Regular smokers (I)</a><br />
45. Pregnant women smoking (D)<br />
46. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=46a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Total (recorded + unrecorded) alcohol consumption (I)</a><br />
<img alt="euhi" src="http://ec.europa.eu/health/indicators/pics/euhi.jpg" height="26" style="border: 0px; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px;" title="euhi" width="85" /><a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=46b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Total (recorded) alcohol consumption</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
47. Hazardous alcohol consumption (D)<br />
48. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=48" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Use of illicit drugs (I)</a><br />
49. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=49" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Consumption of fruit (I)</a><br />
50. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=50" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Consumption of vegetables (I)</a><br />
51. Breastfeeding (D)<br />
52. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=52" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Physical activity (I)</a><br />
53. Work-related health risks (D)<br />
54. Social support (D)<br />
55. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=55" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">PM (particulate matter) exposure (I)</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
<a href="https://www.blogger.com/null" name="id4" style="border: 0px; color: #027ac6; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: underline;"></a></div>
<h3 style="background: url("/health/images/informative/arrow.gif") 0px 3px no-repeat rgb(255, 255, 255); border: 0px; color: #0065a2; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 1.4em; line-height: 1.1em; margin: 18px 0px 6px; outline: none; padding: 0px 0px 0px 15px; text-align: justify;">
Health interventions: health services</h3>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
56. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=56" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Vaccination coverage in children (I)</a><br />
57. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=57" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Influenza vaccination rate in elderly (I)</a><br />
58. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=58" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Breast cancer screening (I)</a><br />
59. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=59" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Cervical cancer screening (I)</a><br />
60. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=60" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Colon cancer screening (I)</a><br />
61. Timing of first antenatal visits among pregnant women (D)<br />
62. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=62" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Hospital beds (I)</a><br />
63. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=63" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Practising physicians (I)</a><br />
64. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=64a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Practising nurses (I)</a><br />
<img alt="euhi" src="http://ec.europa.eu/health/indicators/pics/euhi.jpg" height="26" style="border: 0px; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px;" title="euhi" width="85" /><a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=64b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">European health indicator on other health professionals</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
65. Mobility of professionals (D)<br />
66. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=66" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Medical technologies: MRI units and CT scans (I)</a><br />
67. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=67" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Hospital in-patient discharges, limited diagnosis (I)</a><br />
68. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=68" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Hospital day cases, limited diagnoses (I)</a><br />
69. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=69" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Hospital day-cases as percentage of total patient population (in-patients & day-cases), selected diagnoses (I)</a><br />
70. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=70" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Average length of stay (ALOS), limited diagnoses (I)</a><br />
71. General practitioner (GP) utilisation (D)<br />
72. Selected outpatient visits (D)<br />
<img alt="euhi" src="http://ec.europa.eu/health/indicators/pics/euhi.jpg" height="26" style="border: 0px; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px;" title="euhi" width="85" /><a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=72" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">European health indicator on self-reported visits to a dentist or orthodontist</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
73. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=73" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Selected surgeries (I)</a><br />
74. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=74" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Medicine use, selected groups (I)</a><br />
75. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=75" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Patient mobility (I)</a><br />
76. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=76" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Insurance coverage (I)</a><br />
77(a). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=77a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Expenditures on health care as percentage of GDP (I)</a><br />
77(b). <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=77b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Expenditures on health care in millions of Purchasing Power Standard (PPS) (I)</a><br />
78. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=78" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Survival rates cancer (I)</a><br />
79. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=79" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">30-day in-hospital case-fatality of acute myocardial infarction (AMI) and ischemic stroke (I)</a><br />
80. <a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=80a" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">Equity of access to health care services (I)</a><br />
<img alt="euhi" src="http://ec.europa.eu/health/indicators/pics/euhi.jpg" height="26" style="border: 0px; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px;" title="euhi" width="85" /><a href="http://ec.europa.eu/health/dyna/echi/datatool/index.cfm?indlist=80b" style="border: 0px; color: #3983bb; font-family: inherit; font-style: inherit; margin: 0px; outline: none; padding: 0px; text-decoration: none;" target="_blank">European health indicator on equity of access to dental care services</a><br />
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
81. Waiting times for elective surgeries (D)<br />
82. Surgical wound infections (D)<br />
83. Cancer treatment quality (D)<br />
84. Diabetes control (D)</div>
<h3 style="background: url("/health/images/informative/arrow.gif") 0px 3px no-repeat rgb(255, 255, 255); border: 0px; color: #0065a2; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 1.4em; line-height: 1.1em; margin: 18px 0px 6px; outline: none; padding: 0px 0px 0px 15px; text-align: justify;">
Health interventions: health promotion</h3>
<div style="background-color: white; border: 0px; color: #666666; font-family: Arial, Verdana, Helvetica, sans-serif; font-size: 12px; line-height: 18px; margin: 0px; outline: none; padding: 0px; text-align: justify;">
<br style="border: 0px; margin: 0px; outline: none; padding: 0px;" />
85. Policies on environmental tobacco smoke (ETS) exposure (D)<br />
86. Policies on healthy nutrition (D)<br />
87. Policies and practices on healthy lifestyles (D)<br />
88. Integrated programmes in setting, including workplace, schools, hospital (D)</div>
<br />
<b>Source</b><br />
<br />
<a href="http://ec.europa.eu/health/index_en.htm" target="_blank">European Commission Public Health</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-84834658844182988662016-01-12T18:13:00.000+02:002016-01-12T18:13:26.082+02:00The Older Patient: eHealth and mHealth Approach in Today's Context of Demographic Ageing <div dir="ltr" style="text-align: left;" trbidi="on">
<div>
<br /></div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://healthmanagement.org/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="68" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgveRTD3xQk1M7BFeBsZXRhC-Yf6hwVY9ncNX8K5QVknz3c3I14CbmUhQUy1qq5dbnXvUQSb2ir3ILXf0gON-9FPzV8wvFNYZib6BL1p5YQjVxcBpK1q2YSBtaMPS6obfx3yjlc2w/s320/hlogo.jpg" width="320" /></a></div>
<br />
<div class="articleText" data-mercury="full" id="text" itemprop="articleBody" style="box-sizing: border-box; color: #46494c; font-family: arial; line-height: 24px; margin: 18px 0px;">
<div style="box-sizing: border-box; line-height: 24px; margin: 18px 0px;">
<h3 style="box-sizing: border-box; color: inherit; font-family: inherit; font-weight: 500; line-height: 1.1; margin: 10px 0px;">
<span style="box-sizing: border-box; font-weight: 700;"><span style="font-size: small;">Background</span><span style="font-size: 22px;"> </span></span></h3>
</div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
The demographic trends projected over the long term reveal that Europe is ‘turning increasingly grey’ in the coming decades. By 2025 more than 20 percent of Europeans will be 65 or over, with a particularly rapid increase in the number of over 80s. This ageing trend will continue, and it is expected that by 2060 more than 30 percent will be 65 or over and the number of over 80s will reach 12 percent of the population. While in most parts of Europe life expectancy at birth continues to increase, the healthy life year expectancy is however not increasing in parallel and is even decreasing in some countries. This means that we can expect a sharp rise in the number of older people who will need support if nothing is done in the near future to empower them to cope with chronic diseases, old age frailty and the limitations on their daily activities that result from their health conditions. The rapid ageing of the population must be reflected in a greater empowerment of older citizens and consumers in all relevant areas and in particular in the whole innovation process of eHealth and mHealth solutions.</div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
<a name='more'></a><br /></div>
<div style="box-sizing: border-box; line-height: 24px; margin: 18px 0px;">
<h3 style="box-sizing: border-box; color: inherit; font-family: inherit; font-weight: 500; line-height: 1.1; margin: 10px 0px;">
<span style="box-sizing: border-box; font-weight: 700;"><span style="font-size: small;">Empowering Patients: From Theory to Practice </span></span></h3>
</div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
Many innovative eHealth and mHealth solutions are being developed in Europe today. Not all make it to their national market and even fewer are scaled up cross-border. The industry and policymakers are struggling to find ways to overcome the technical and structural barriers that hamper the development of a digital single market for eHealth and mHealth solutions. <span style="box-sizing: border-box; font-weight: 700;"><br style="box-sizing: border-box;" /></span></div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
But there are also other barriers, such as the huge differences in terms of health and digital literacy among older persons, between countries and the passive reluctance from a significant part of the demand side. This comes <span style="box-sizing: border-box; font-size: 12px;"> </span>mainly from older patients but also carers, who are not so easily convinced of the added value such products would bring them.</div>
<div style="box-sizing: border-box; line-height: 24px; margin: 18px 0px;">
<h3 style="box-sizing: border-box; color: inherit; font-family: inherit; font-weight: 500; line-height: 1.1; margin: 10px 0px;">
<span style="box-sizing: border-box; font-weight: 700;"><span style="font-size: small;">Make it Relevant for the Target Group</span><span style="font-size: 22px;"> </span></span></h3>
</div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
Let’s take for example the electronic pill dispenser, which is promoted as an innovative way to support adherence to treatment, a major challenge among older people living at home. Just like a classical pill dispenser, the electronic dispenser has to be filled in once a week with medication divided per day and time of the day. <span style="box-sizing: border-box; font-weight: 700;"><br style="box-sizing: border-box;" /></span></div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
The advantage of the classical dispenser is that it is much smaller and you can carry it easily in your bag when you go out for a meal or on holiday. The advantage of the electronic dispenser is that it beeps when the patient needs to take a pill and it alerts the informal carer or physician if the patient forgets to take the pill out of the box at the pre-set time. Such a system can be helpful for people who live alone at home and have very severe health conditions for which it is really important to take certain medication at a given time. But what if the patient is unable to hear the beep, if he or she is having a nap (frail older people tend to take several naps during the day), has left the room to go to the bathroom or is sitting in the garden? </div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
Most older people are prescribed a range of medications that should be taken around meals. They usually start their meal by emptying their pill box compartment on the table near their glass. Older patients are quite good at taking the pill(s) that have to be swallowed before they start eating, but some tend to forget the medication that has to be taken during or after the meal. The electronic pillbox does not help if they forget their pill(s) on the table and it gets thrown away with the breadcrumbs at the end of the meal, a scenario which is rather common among older people. </div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
So, with the exception of those with very severe health conditions who are living alone, many older people just wonder what added value there is for them to have an electronic pill dispenser, which only reacts if they have not taken their pill out of the box at a certain time, but does not help them remember whether they really took their medication or not. </div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
Many older people are also reluctant to use electronic devices that would alert a relative or carer whenever something is detected, for fear of false alarms, because they do not want to overburden their carer, or have no close relative or friend who could take up that role. Regardless of the type of dispenser used, a very simple way that can help many older patients check whether they have taken all their medication is by putting the pill(s) on a small cup near the glass. It is very easy then to see if the patient is adhering to their treatment. </div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
Another barrier that is common with eHealth and mHealth solutions is the reluctance of many older people to be monitored all day long. No one will contest the benefit of monitoring vital functions, in acute care patients. Yet, because the technology is available, the industry’s interest is to equip older patients — and even healthy people — with 24/7/365 monitoring of their vital functions, and some present this as a pre-requirement to ageing at home. </div>
<div style="box-sizing: border-box; font-size: 14px; line-height: 24px; margin: 18px 0px;">
The push should not come from the industry, because older people do not necessarily see the need for such solutions and do not know what solutions to trust. The voluntary certification scheme set up by the <a href="http://www.juntadeandalucia.es/agenciadecalidadsanitaria/en/" style="box-sizing: border-box; color: #0645ad; text-decoration: none;" target="_blank">Andalusian Agency for Healthcare Quality</a> is an interesting example of what can be done to better match needs, to overcome older people’s reluctance and help them access the benefits of eHealth and mHealth solutions that have proved useful, safe and effective. </div>
</div>
<b><br /></b>
<b>You can read the whole article <a href="https://healthmanagement.org/c/healthmanagement/issuearticle/the-older-patient-ehealth-and-mhealth-approach-in-today-s-context-of-demographic-ageing" target="_blank">HERE</a>.</b><br />
<b><br /></b>
<b>Source</b><br />
<br />
<a href="https://healthmanagement.org/" target="_blank">HealthManagement.org</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-6847735822100058022016-01-02T11:05:00.004+02:002016-01-02T15:27:22.515+02:00Congresses for Hospital Pharmacists during 2016<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="http://2.bp.blogspot.com/-mh2cmw0QKYM/VoeaQ7obUUI/AAAAAAAAVIU/24W-_BhZ_bE/s1600/presenting_to_audience_md_wm3.gif" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/-mh2cmw0QKYM/VoeaQ7obUUI/AAAAAAAAVIU/24W-_BhZ_bE/s1600/presenting_to_audience_md_wm3.gif" /></a></div>
<br />
Here are our proposals for the Congresses and Scientific Events during the year<span style="color: #009900; font-weight: bold;"> 2016</span>!<br />
<div dir="ltr" style="text-align: left;" trbidi="on">
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.eahp.eu/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="152" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh4HWu0_eB8fi-NLDSOxzbmHkmUao8oVPos9_oZmNEyqiHq8UHsqb7t5QopW5zzjEui76cNxlwYAnh22o2-ehSGF0l1qNffAH3TbexwaeDQ9zsP7htYlNVr2XqKbQKnA0xr2YGIkw/s200/eahp.png" width="200" /></a></div>
<br />
<a href="http://www.eahp.eu/" target="_blank">EAHP European Association of Hospital Pharmacists</a><br />
<a href="http://www.eahp.eu/congresses/21st-congress-eahp" target="_blank">http://www.eahp.eu/congresses/21st-congress-eahp</a><br />
21st Congress of the EAHP<br />
16-18 March 2016<br />
Vienna, Austria<br />
Download the programme flyer from <a href="http://www.eahp.eu/congresses/21st-congress-eahp/programme" target="_blank">HERE</a><br />
Website: <a href="http://www.eahp.eu/congresses/21st-congress-eahp" target="_blank">http://www.eahp.eu/congresses/21st-congress-eahp</a><br />
<br />
<br />
<br />
<a href="http://www.esop.li/futureevents.php" onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}"><img alt="" border="0" id="BLOGGER_PHOTO_ID_5151882912334851954" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgxZNFhHSlDWEHYaqnsr7W-TG9x-Aj7KuigPVMFAPwmO0mn2_GOCwjShs5dhf9sHkEVOpXr_NAmQtNgKGrxsA7VDXcDbcVRj6EljUKPaL0312h1OjkYr7Our74hmyj72lf8kXmNkA/s200/esoplog.gif" style="float: left; height: 104px; margin: 0pt 10px 10px 0pt; width: 115px;" /></a><a href="http://www.esop.li/futureevents.php">ESOP European Society for Oncology Pharmacists</a><br />
<a href="http://www.esop.li/futureevents.php">http://www.esop.li/futureevents.php</a><br />
3rd European Conference of Oncology Pharmacy,<br />
19th – 21st May 2016<br />
Dubrovnik, Croatia<br />
Download the programme flyer from <a href="http://www.esop.li/downloads/Flyer_ecop3.pdf" target="_blank">HERE</a><br />
Website: <a href="http://www.ecop2016.eu/" target="_blank">www.ecop2016.eu</a><br />
<br />
<br />
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.fip.org/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiVkJgpUtNvWCLKT5gKyRE6w-sYKnrzl3wLCmO6N6G7xSZzpgtK_5KAIT3RHuRc3kyYcOudyNyyia1wndhYP273UvYmn5My3S0cY6uR7X_3VILKwcCRVFAs2m0OY2qL7ZMZDopLdg/s1600/fiplogocomplete.jpg" /></a></div>
<a href="http://www.fip.org/" target="_blank">FIP International Pharmaceutical Federation</a><br />
<a href="http://www.whpa.org/whpcr2016/" target="_blank">http://www.whpa.org/whpcr2016/</a><br />
World Health Professions Conference on Regulation 2016<br />
21 May - 22 May 2016<br />
Geneva, Switzerland<br />
<br />
<br />
<br />
<a href="http://www.escpweb.org/cms/" onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}"><img alt="" border="0" id="BLOGGER_PHOTO_ID_5151884265249550242" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEje4R0Gz9AXpWtmZtDRN88unFzvXDN7YMvXXaZd9Z0ZKrJbkYHAW5jSkIBu_3P9XU4UthPRbmhmn7Qgp_zIHsweUfWtC9qzk1VCJ97TH9PeZ4yDlSA4qnIiprLh-wBPh0oR6taVAA/s200/ESCP_logoTop2.gif" style="float: left; height: 68px; margin: 0pt 10px 10px 0pt; width: 147px;" /></a><a href="http://www.escpweb.org/cms/" target="_blank">ESCP European Society of Clinical Pharmacy</a><br />
Workshop<br />
<a href="http://www.escpweb.org/cms/" target="_blank">http://www.escpweb.org/cms</a><br />
<span style="background-color: white; color: #333333; font-family: inherit; text-align: center;">June 10-11 2016</span><br />
<span style="background-color: white; color: #333333; text-align: center;"><span style="font-family: inherit;">Spring Workshop in Basel, Switzerland, </span></span><br />
<div style="text-align: center;">
<br /></div>
<a href="http://www.ispor.org/" onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}"><img alt="" border="0" id="BLOGGER_PHOTO_ID_5151888276749004754" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhLgBey0BgQV_EvUoJzF6S0j1g_LNEILgnjZWI3GFLVdvlchryOMnuboc2tO4PYbkLikRJt8bIZ9c_-gKv6z0yXL9z6oKJaEYczIENl2PYOxUvPusPqj8yLV4TyRrHAn67d9pcviw/s200/ISPOR-small.jpg" style="float: left; margin: 0pt 10px 10px 0pt;" /></a><br />
<br />
<a href="http://www.ispor.org/" target="_blank">ISPOR International Society for Pharmacoeconomics and Outcomes Research</a><br />
<a href="http://www.ispor.org/Events/Index.aspx?eventId=27">http://www.ispor.org/Events/Index.aspx?eventId=27</a><br />
<span style="font-family: inherit;"><a href="http://www.ispor.org/Event/Index/2016Vienna" style="color: #0a4d3b; text-decoration: none;">ISPOR 19th Annual European Congress</a><br /><span style="background-color: white;">29 October-2 November 2016</span><br /><span style="background-color: white;">Vienna, Austria</span></span><br />
Website: <a href="http://www.ispor.org/Event/Index/2016Vienna" target="_blank">http://www.ispor.org/Event/Index/2016Vienna</a><br />
<br /></div>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-58724550969973386402015-12-30T08:56:00.004+02:002015-12-30T08:56:25.217+02:00Happy New Year 2016<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhamjRStsypTeDLZs_KD2BlP318sQJx5DMQnDtTAcVbR7A1w_ovjtenDhr_BUainFV5TIbDJ-xo7QNh9AgPPlSupv7Rq_W1JXC5KWYELv4riPfgVfBlsCHov18GB7JYJm6QO9ucTw/s1600/new_year_2016__animated.gif" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhamjRStsypTeDLZs_KD2BlP318sQJx5DMQnDtTAcVbR7A1w_ovjtenDhr_BUainFV5TIbDJ-xo7QNh9AgPPlSupv7Rq_W1JXC5KWYELv4riPfgVfBlsCHov18GB7JYJm6QO9ucTw/s1600/new_year_2016__animated.gif" /></a></div>
<br />
<div style="text-align: center;">
<b><span style="color: #38761d;">Wish You A...</span></b></div>
<div style="text-align: center;">
<b><span style="color: #cc0000;">Great, Prosperous,</span> </b></div>
<div style="text-align: center;">
<b><span style="color: blue;">Healthy, Bright, Delightful,</span> </b></div>
<div style="text-align: center;">
<b><span style="color: #783f04;">Terrific & Extremely ...happy</span><span style="color: #e69138;">, </span></b></div>
<div style="text-align: center;">
<b><span style="color: #274e13;">HAPPY NEW YEAR 2016
</span></b></div>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-54703662257140514032015-12-18T10:51:00.000+02:002015-12-18T10:52:13.958+02:00Third European Conference of Oncology Pharmacy (ECOP)<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgOvFDrwlDAfMdYzmj8RhOJejYn9Dq_1aJk-fBcckZstwFXYmFzmSrRW9Dq8f4TpKKaoZJ36mCm8NSbjAHP4YuI6RfnwFN4OuhtJZQF95Q8fAu9i96yfNP2_jIjDFqsljhTl2AOuw/s1600/esoplog.gif" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgOvFDrwlDAfMdYzmj8RhOJejYn9Dq_1aJk-fBcckZstwFXYmFzmSrRW9Dq8f4TpKKaoZJ36mCm8NSbjAHP4YuI6RfnwFN4OuhtJZQF95Q8fAu9i96yfNP2_jIjDFqsljhTl2AOuw/s1600/esoplog.gif" /></a></div>
<br />
The <b><a href="http://www.esop.li/" target="_blank">European Society of Oncology Pharmacy (ESOP)</a></b>, founded in 2000 in Prague, is the largest organisation of <b>oncology pharmacists</b> in the world with almost<b> 3000 members from 46 countries</b>.<br />
<br />
The aim of <b><a href="http://www.esop.li/" target="_blank">ESOP </a></b>is to support optimal treatment for cancer patients, to develop and promote clinical and oncology pharmacy practice through education and training, safe handling and administration of drugs, quality management, research and development and pharmaceutical care.<br />
<br />
The announcement for the <b><a href="https://ecop2016.wordpress.com/" target="_blank">3rd European Conference of Oncology Pharmacy</a></b> has been posted in the website of ESOP and here is the welcome from the President.<br />
<br />
<br />
<a name='more'></a><br /><br />
On behalf of the European Society of Oncology Pharmacy (ESOP) and the Organizing Committee, we warmly welcome you to the third European Conference of Oncology Pharmacy (ECOP), in the time-honored city of Dubrovnik, Croatia, at 19-21 May 2016.<br />
The experiences of the last two meetings, 2012 in Budapest, Hungary and 2014 in Krakow, Poland, have reassured us of the importance of an exchange not only on a national but on an European level as well.<br />
We are very thankful for the support our meetings have received by the EU Commission and were overwhelmed by the reception of the conferences by both participants and partners from pharmaceutical companies.<br />
We will strive not only to meet the success of the former conferences but to excel it, especially regarding the scientific level.<br />
Close co-operation between oncology physicians and oncology pharmacists is essential for optimal patient care. ECOP 2016 offers a tremendous opportunity for exchange and debate between its over 3.000 members and colleagues and partners worldwide.<br />
The primary focus of this unique European Conference is to promote the highest standards of pharmaceutical care in the management and support of patients with tumors. The latest advances in research, patient management and practice are being showcased in keynote lectures, scientific symposia and poster sessions in two distinct tracks, clinical and practical.<br />
We know that a multi-professional, multidisciplinary approach in oncology will not only ensure economic use of resources but also significantly improve patient safety.<br />
We would like to take this opportunity to invite you to the Opening Event held in the exhibition area of the Conference venue, providing you the opportunity to meet colleagues from around the world, to network in a convivial setting and forge new links for future collaboration.<br />
Lastly, but by no means least, our host city will match the exciting promise of the Conference itself. Speakers, participants, guests and friends should make time to discover the wonderful city that is Dubrovnik with its wealth of historical buildings.<br />
We trust that you will return from the Conference inspired by colleagues from around the world and that you will have made new friends and scientific contacts that will support you in your essential work.<br />
We are delighted to be welcoming you to what promises to be a highly educational, collaborative and successful conference.<br />
Yours,<br />
Klaus Meier<br />
President of ESOP EJOP (European Journal of Oncology Pharmacy)<br />
<br />
<b>Source </b><br />
<br />
<a href="https://ecop2016.wordpress.com/" target="_blank">ESOP</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-21609608830363839032015-12-17T11:21:00.003+02:002016-01-02T11:48:35.567+02:00Recommendations on medication errors from EMA - European Medicines Agency<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.ema.europa.eu/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhFbqTmbQ7aq-H6ZlZ83FJ8oDdXsh9Nv8OJPCCqmLTFBH6NWAiWnt1uGOQZwuxZbAio1QDFoMS39kZ-6I41pNy7rGRF85WmqA7ny-Rv6qigEazYi1DQL23UI_p1MoKJMyvFe0Tudw/s1600/ema.gif" /></a></div>
<br />
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
<span style="background: transparent; border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">In the <b><a href="http://europa.eu/" target="_blank">European Union (EU)</a></b>, national competent authorities and the <b><a href="http://www.ema.europa.eu/" target="_blank">European Medicines Agency (EMA)</a></b> play a key role in identifying and reducing the risk of medication errors before and after the authorisation of a medicine. <span style="background-attachment: initial; background-clip: initial; background-image: initial; background-origin: initial; background-position: initial; background-repeat: initial; background-size: initial; border: 0px; font-size: 1em; margin: 0px; padding: 0px; vertical-align: baseline;">EMA applies a consistent approach to communicating to patients and healthcare professionals on any additional measures recommended by the Agency to reduce the risk of medication errors with a specific medicine. </span></span></div>
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
A medication error is a mistake in the use of a medicine that can be harmful for a patient. Medication errors occur at the time of prescribing, dispensing, storing, preparing and administering of a medicine. While the overall number of medication errors leading to harm is small, the impact on patients and health care systems can be high.<br />
<br />
<br />
<a name='more'></a><br /></div>
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
The <strong style="background: transparent; border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">routine risk-minimisation measures</strong> to prevent medication errors national competent authorities and EMA apply include ensuring that:</div>
<ul style="background: rgb(255, 255, 255); border: 0px; clear: left; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; list-style: none; margin: 0px 0px 15px; padding: 0px; vertical-align: baseline;">
<li style="background: url("../images/icon_arrow-grey.gif") 0% 0.25em no-repeat; border: 0px; height: 16px; margin: 0px 0px 4px; padding: 0px 0px 0px 12px; vertical-align: top;">the proposed name of a medicine does not sound similar to the name of another medicine;</li>
<li style="background: url("../images/icon_arrow-grey.gif") 0% 0.25em no-repeat; border: 0px; height: 16px; margin: 0px 0px 4px; padding: 0px 0px 0px 12px; vertical-align: top;">the labelling of a medicine does not look similar to the labelling of other medicines;</li>
<li class="last" style="background: url("../images/icon_arrow-grey.gif") 0% 0.25em no-repeat; border: 0px; height: 16px; margin: 0px 0px 4px; padding: 0px 0px 0px 12px; vertical-align: top;">the instructions in the <span class="glossary-term" style="background: transparent; border-bottom-color: rgb(0, 0, 0); border-bottom-style: dotted; border-width: 0px 0px 1px; font-size: 1em; margin: 0px !important; padding: 0px; vertical-align: baseline;">product information</span> on the use of the medicine are clear so as not lead to medication errors.</li>
</ul>
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
<br />
For more information on regulatory measures for the pharmaceutical industry, see <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000570.jsp&mid=WC0b01ac0580659655" style="background: transparent; border: 0px; color: #003399; cursor: pointer; font-size: 1em; margin: 0px; padding: 0px; text-decoration: none; vertical-align: baseline;">Medication errors</a>.</div>
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
In cases where the risk of medication errors is high and routine measures are not considered sufficient, <strong style="background: transparent; border: 0px; margin: 0px; padding: 0px; vertical-align: baseline;">additional measures</strong> are taken to ensure that the medicine is used correctly, including educational programmes for healthcare professionals and patients.<br />
<br /></div>
<h3 style="background: rgb(255, 255, 255); border: 0px; color: #333333; font-family: Verdana, Tahoma, sans-serif; font-size: 1.2em; line-height: 1.2em; margin: 0px 0px 11px; padding: 0px; vertical-align: baseline;">
Reporting medication errors</h3>
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
Although regulators assess the potential risk of medication errors before marketing approval, medication errors may still occur after a medicine is authorised and used. Patients and healthcare professionals should report any errors they experience to prevent further ones. Timely reporting allows regulatory authorities to implement risk-minimisation measures at an early stage as necessary.</div>
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
Patients may directly report any suspected side effects including those caused by medication errors. For more information, see <a class="external" href="http://www.adrreports.eu/en/report_side_effect.html" style="background: transparent; border: 0px; color: #003399; cursor: pointer; font-size: 1em; margin: 0px; padding: 0px; text-decoration: none; vertical-align: baseline;" target="_blank">How to report a side effect<img alt="External link icon" class="ext" src="http://www.ema.europa.eu/ema/images/icon_link-external.gif" style="background: transparent; border: none !important; float: left; margin: 0px 10px 10px 0px; padding: 0px 0px 0px 3px; position: static; vertical-align: baseline;" /></a>.</div>
<h3 style="background: rgb(255, 255, 255); border: 0px; color: #333333; font-family: Verdana, Tahoma, sans-serif; font-size: 1.2em; line-height: 1.2em; margin: 0px 0px 11px; padding: 0px; vertical-align: baseline;">
Communications <strong style="background: transparent; border: 0px; font-size: 14.4px; margin: 0px; padding: 0px; vertical-align: baseline;">to patients and healthcare professionals</strong></h3>
<div style="background: rgb(255, 255, 255); border: 0px; clear: none; font-family: Verdana, Tahoma, sans-serif; font-size: 12px; line-height: 16.8px; margin-bottom: 15px; padding: 0px; vertical-align: baseline;">
In order to promote the safe use of medicines, EMA systematically communicates on any additional measure decided upon at EU level to prevent medication errors. The purpose of these documents is to increase awareness of the additional measures recommended by EMA in order to ensure that a specific medicine is used correctly and to reduce the risk of medication errors. These communications are accessible below and via the <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124" style="background: transparent; border: 0px; color: #003399; cursor: pointer; font-size: 1em; margin: 0px; padding: 0px; text-decoration: none; vertical-align: baseline;">European public assessment reports</a> of these medicines.</div>
More info <b><a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000398.jsp&mid=WC0b01ac058098f1c0" target="_blank">HERE</a></b>.<br />
<br />
<b>Source</b><br />
<br />
<a href="http://www.ema.europa.eu/" target="_blank">EMA</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-83793549299231671952015-12-06T21:25:00.003+02:002016-01-02T11:48:56.301+02:00European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages)<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.cost.eu/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="41" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEidxpOf_E6qnahEGiqrQSTH40_SmXJmiyooF-PKCdqsoXFI9xuXQ75arohEctLM0bY8sB5XEWQbATlo1ZA0dKcrvZ7zvJXiA5YCrpKkkA_5qUFx5AWoSaz8wkGyDWh7z4n2cgNkWg/s200/logo_cost.png" width="200" /></a></div>
<br />
The problems created by supply<b> shortages of medicines</b> have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. The cited causes are <b>multifaceted ranging from production disruptions, natural disasters, discontinuations</b> as well as difficulties created by various legal, trade and pricing frameworks.<br />
<br />
<b>Healthcare professionals</b> require access to reliable and up-to-date information about the unavailability of a medicine in order that they can treat the patient in the best way possible. The <b>significant patient impact</b> because of the lack of medication, in terms of safety and management of their condition, will be researched. In addition the forced <b>substitution to an alternative product or requirement to produce a medicine </b>may increase the <b>risk of error, stress and overall cost to the healthcare system</b>.
According to the largest pan-European survey of healthcare professionals yet conducted on the topic, <b>the products mainly affected in the European hospital sector are antimicrobials and oncology products</b> used for large populations.<br />
<br />
<br />
<a name='more'></a><br /><br />
This Action will encourage <b>systematic sharing of information and research about past, ongoing and future shortages of medicines and nutritional product</b>s. The Action aims to respond to clinical, financial and quality of life interests, to achieve analytical clarity on disruption causes, to simulate decision making in medicines production and trade, to highlight restrictive legal and economic frameworks, to disclose disincentives in the supply chain such as conflicts of interest or problematic cost-benefit ratios, and to reflect on best coping practices.
<br />
<br />
<br />
<b>About COST</b><br />
<br />
<b><a href="http://www.cost.eu/" target="_blank">COST</a></b> is the longest-running European framework supporting trans-national cooperation among researchers, engineers and scholars across Europe.
<br />
<br />
It is a unique means for them to jointly develop their own ideas and new initiatives across all fields in science and technology, including social sciences and humanities, through pan-European networking of nationally funded research activities. Based on a European intergovernmental framework for cooperation in science and technology, COST has been contributing - since its creation in 1971 - to closing the gap between science, policy makers and society throughout Europe and beyond. As a precursor of advanced multidisciplinary research, COST plays a very important role in building a <b><a href="http://ec.europa.eu/research/era/index_en.html" target="_blank">European Research Area </a></b>(ERA).<br />
<br />
It anticipates and complements the activities of the EU Framework Programmes, constituting a “bridge” towards the scientific communities of COST Inclusiveness Target Countries. It also increases the mobility of researchers across Europe and fosters the establishment of scientific excellence.<br />
<br />
<br />
<b>Related links</b><br />
<span style="font-family: inherit;"><br /></span>
<br />
<br />
<li style="border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://issuu.com/costprogramme/docs/cost_corporate_brochure" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" title="new browser window"><span style="font-family: inherit;">COST brochure on ISSU</span></a></li>
<li style="border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/programmes/horizon2020/en" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" title="new browser window"><span style="font-family: inherit;">Horizon 2020</span></a></li>
<li style="border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/programmes/horizon2020/en/h2020-section/future-and-emerging-technologies" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" title="new browser window"><span style="font-family: inherit;">FET - Future and Emerging Technologies </span></a></li>
<li style="border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/research/index.cfm?pg=why&lg=en" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" title="new browser window"><span style="font-family: inherit;">Why European Research?</span></a></li>
<li style="border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/research/era/index_en.htm" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" title="new browser window"><span style="font-family: inherit;">European Research Area (ERA)</span></a></li>
<li style="border-bottom-color: rgb(224, 224, 224); border-bottom-style: solid; border-width: 0px 0px 1px; line-height: 1.25em; margin: 0px; padding: 0px;"><a class="arrow neues-fenster" href="http://ec.europa.eu/research/index.cfm" style="background-image: url(http://www.cost.eu/design/cost/images/icons/arrow_orange.gif); background-position: 4px 0.82em; background-repeat: no-repeat no-repeat; color: #2b6f93; display: block; padding: 0.5em 5px 0.5em 12px; text-decoration: none;" title="new browser window"><span style="font-family: inherit;">Research at the European Commission</span></a></li>
<span style="font-family: inherit;"><br /></span>
<b><span style="font-family: inherit;">Sources</span></b><br />
<br />
<a href="http://www.cost.eu/" target="_blank">COST network</a><br />
<a href="http://www.cost.eu/COST_Actions/ca/CA15105" target="_blank"><br /></a>
<a href="http://www.cost.eu/COST_Actions/ca/CA15105" target="_blank">http://www.cost.eu/COST_Actions/ca/CA15105 </a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-72228732036862757062015-11-23T11:35:00.001+02:002015-11-23T12:22:23.437+02:00Refugees : Commissioner Andriukaitis presents the Personal Health Record in Greece<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhcyeysppDwSE3h1a_8ugfQKEu008CUlJFrLmbwlC7DI8RzPwDKcAMrfRRDUOe-WHsHmHMYpWAEYani_M86GKI3Dmnvy2ONufAD54TkwI6XpDUfSLGO5KhpZIg3Kr8FEF8fCvDz5A/s1600/logo_en.gif" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhcyeysppDwSE3h1a_8ugfQKEu008CUlJFrLmbwlC7DI8RzPwDKcAMrfRRDUOe-WHsHmHMYpWAEYani_M86GKI3Dmnvy2ONufAD54TkwI6XpDUfSLGO5KhpZIg3Kr8FEF8fCvDz5A/s1600/logo_en.gif" /></a></div>
<br />
On Thursday, during a visit in Greece, Commissioner <b>Andriukaitis</b> presented the <b>"Personal Health Record" (PHR)</b> to Greek authorities in Athens and to NGOs on the island of Lesbos, where he visited a centre for refugees.<br />
<br />
This document prepared by the Commission, together with the <b><a href="http://www.iom.int/" target="_blank">International Organisation for Migration (IMO)</a></b>, will be made available at the Hotspots, to evaluate migrants' medical needs and help reconstruct their medical history.<br />
<br />
The PHR is accompanied by a Handbook to be used by health professionals.<br />
<br />
<br />
<a name='more'></a><br /><br />
<br />
<b>Documents: </b><br />
<b><br /></b>
<a href="http://ec.europa.eu/dgs/health_food-safety/docs/personal_health_record_english.pdf" target="_blank"><b>Personal health record</b></a><br />
<a href="http://ec.europa.eu/dgs/health_food-safety/docs/personal_health_handbook_english.pdf" target="_blank"><b>Handbook for Health professionals</b></a><br />
<br />
<b>Source</b><br />
<br />
<a href="http://ec.europa.eu/health/index_en.htm" target="_blank">EC Public Health</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-13579417396720250262015-11-14T11:40:00.003+02:002016-01-02T11:49:11.264+02:00eHealth Standards and Profiles in Action for Europe and Beyond<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.estandards-project.eu/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiyq9NNntPweVrEwUT8yGgdoSbZ-hdt1b_wgJRx7IHu2I7ahk_m_BLvlhZGTSkZ0OCL8uA31ni0PoaCpOKxAfX2BzVrnKF8fbcNnG-sPyHeh3YRKv5FQNv3UQTHQct2TsN_Id8sPQ/s1600/estandards.gif" /></a></div>
<br />
<div style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px;">
<br /></div>
<div style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px;">
<span style="font-family: inherit;">The eStandards CSA is proposed by HL7, CEN TC251, & IHE, leading Standards Organizations (SDOs), and is supported by the eHealth Network, ISO TC215, GS1, IHTSDO, IEEE11073, and IMIA to advance eHealth interoperability and global alignment of standards with seven objectives:</span></div>
<div style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px;">
<span style="font-family: inherit;"><br /></span></div>
<ol style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px; margin-top: 0px;">
<li style="box-sizing: border-box;"><span style="font-family: inherit;">Join up with Stakeholders in Europe and globally to build consensus on eHealth standards, accelerate knowledge-sharing, and promote wide adoption of standards.</span></li>
<li style="box-sizing: border-box;"><span style="font-family: inherit;">Deliver an evidence-based Roadmap for alignment, iterative consolidation, and broad acceptance of eStandards that is endorsed by SDOs, the eHealth Network, the providers, and the Industry.</span></li>
<li style="box-sizing: border-box;"><span style="font-family: inherit;">Contribute to the eHealth Interoperability Framework use cases focusing on clinical content modelling for different paradigms and embed a Quality Management System for interoperability testing and certification of eHealth systems.</span></li>
<li style="box-sizing: border-box;"><span style="font-family: inherit;">Collect evidence and provide guidance on the coexistence of competing or overlapping standards in large-scale eHealth deployment nationally and cross-border.</span></li>
<li style="box-sizing: border-box;"><span style="font-family: inherit;">Participate in EU/US MoU roadmap actions as the international patient summaries standard.</span></li>
<li style="box-sizing: border-box;"><span style="font-family: inherit;">Explore socio-economic aspects of eHealth interoperability, revisiting the language for user-vendor interaction that embodies ‘co-making’ in trust, collaboration and long-term engagement.</span></li>
<li style="box-sizing: border-box;"><span style="font-family: inherit;">Align across PHC-34 to nurture innovation, sustainability & growth under CEF and beyond contributing to Key actions of the Digital Agenda 2020.</span></li>
</ol>
<div>
<span style="font-family: "verdana" , "arial" , "helvetica" , sans-serif;"><span style="font-family: inherit; font-size: 14.1667px;"></span></span><br />
<a name='more'></a></div>
<div>
<span style="font-family: "verdana" , "arial" , "helvetica" , sans-serif;"><span style="font-family: inherit; font-size: 14.1667px;"><br /></span></span></div>
<div style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px;">
<span style="font-family: inherit;">The proposal’s ambition is to strengthen Europe’s voice and impact, while reinforcing the bridges established with the EU Patient Summary guideline across the Atlantic in Trillium Bridge and among MS with epSOS, eSENS, Antilope, and EXPAND. </span></div>
<div style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px;">
<span style="font-family: inherit;">The eStandards Roadmap and associated evidence base, a white paper on the need for formal standards, and two guidelines addressing how to work with: </span></div>
<div style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px;">
<span style="font-family: inherit;">a) clinical content in profiles and </span></div>
<div style="box-sizing: border-box; font-family: Verdana, Arial, Helvetica, sans-serif; font-size: 14.166666030883789px; margin-bottom: 10px;">
<span style="font-family: inherit;">b) competing standards in large-scale eHealth deployments will be pragmatic steps toward alignment and convergence.</span></div>
<br />
<b>Source</b><br />
<br />
<a href="http://www.estandards-project.eu/" target="_blank">eHealth Standards</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-32787877074529229372015-11-01T18:57:00.003+02:002015-11-23T12:21:49.209+02:00Educational Webinar: IHE Pharmacy Domain Update<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
</div>
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj8vUET8qkPQ4sW1o0LMOqcmS-V49s-iDEtd2GbgV31jsD0UNO5ZZTb44y84gm4RRskMinWjgZD4PzchNJ_6TYgYrvyjCCHtj3vYKXPAVj2Oeaad_cNK2RdnixVkXHaNQ2keuFstw/s1600/logo.png" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="54" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEj8vUET8qkPQ4sW1o0LMOqcmS-V49s-iDEtd2GbgV31jsD0UNO5ZZTb44y84gm4RRskMinWjgZD4PzchNJ_6TYgYrvyjCCHtj3vYKXPAVj2Oeaad_cNK2RdnixVkXHaNQ2keuFstw/s200/logo.png" width="200" /></a></div>
<br />
<div>
<b><a href="http://www.ihe.net/" target="_blank">IHE (Integrating the Healthcare Enterprise) </a></b>annually presents a series of free educational webinars from June through September.<br />
<br />
The series will help your organization learn about IHE; engage in IHE development and testing activities; and, leverage IHE solutions to develop and implement interoperable health IT systems.
<br />
<br /></div>
<div>
<div style="border: 0px; color: #444444; line-height: 19.8px; margin-bottom: 1em; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;"><b>Pharmacy Overview</b>: </span></div>
<div style="border: 0px; color: #444444; line-height: 19.8px; margin-bottom: 1em; padding: 0px; vertical-align: baseline;">
<span style="font-family: inherit;">PHARM Learning Objectives:</span></div>
<ul style="color: #666666; margin: 0px; padding: 0px;">
<li style="margin: 0px 0px 5px 20px; padding: 0px;"><span style="line-height: 19.8px;"><span style="font-family: inherit;">Understand PHARM vision, mission and strategic goals.</span></span></li>
<li style="margin: 0px 0px 5px 20px; padding: 0px;"><span style="line-height: 19.8px;"><span style="font-family: inherit;">Understand PHARM domain's liaison and collaboration with HL7 and ISO.</span></span></li>
<li style="margin: 0px 0px 5px 20px; padding: 0px;"><span style="font-family: inherit;"><span style="line-height: 19.8px;">Overview of existing PHARM profiles and Community and Hospital Pharmacy, including Community Medication Prescription and Dispense, Hospital Medication Workflow, Medication Treatment Plan </span><span style="line-height: 19.8px;"> </span></span></li>
</ul>
<div>
<span style="color: #666666;"><span style="line-height: 19.8px;"><br /></span></span></div>
<div style="color: #666666; margin-bottom: 5px; margin-top: 5px; padding: 0px;">
<br />
<a name='more'></a><br /></div>
<div style="color: #666666; margin-bottom: 5px; margin-top: 5px; padding: 0px;">
<span style="font-family: inherit;">Overview of other PHARM domain activities, including Supply Chain, EHIR</span></div>
<div style="color: #666666; margin-bottom: 5px; margin-top: 5px; padding: 0px;">
<span style="font-family: inherit;">Understand how PHARM work benefits the pharmacists.</span></div>
<div style="color: #666666; margin-bottom: 5px; margin-top: 5px; padding: 0px;">
<span style="font-family: inherit;">How to get involved in PHARM committee work.</span><br />
<br />
<iframe allowfullscreen="allowfullscreen" frameborder="0" height="337" src="https://www.youtube.com/embed/vNDC35VIKxA" width="600"></iframe>
<span style="font-family: inherit;"><br /></span>
<span style="font-family: inherit;"><br /></span></div>
</div>
<div>
<ul style="list-style-image: url(data:image/gif; list-style-type: square; margin: 0.3em 0px 0px 1.6em; padding: 0px;">
<li style="margin-bottom: 0.1em;"><span style="font-family: inherit;">Webinars are available at the wiki:</span></li>
</ul>
<a href="http://wiki.ihe.net/index.php?title=Pharmacy_Planning_Committee#Webinars">http://wiki.ihe.net/index.php?title=Pharmacy_Planning_Committee#Webinars</a><br />
<ul style="list-style-image: url(data:image/gif; list-style-type: square; margin: 0.3em 0px 0px 1.6em; padding: 0px;">
</ul>
<dl style="margin-bottom: 0.5em; margin-top: 0.2em;"><dd style="margin-bottom: 0.1em; margin-left: 1.6em; margin-right: 0px;"><div>
<span style="font-family: inherit;"><br /></span></div>
</dd></dl>
</div>
<div>
<b><span style="color: #666666; font-family: inherit;">Download the: </span><span style="color: #444444; font-family: "arial" , "helvetica" , sans-serif; font-size: 13px;"><a href="https://ihe.webex.com/ihe/lsr.php?RCID=4c7d88915fcb42dea8d80c05c90c1e7c" style="color: #9c7dbe; text-decoration: none;" title="Recording">Recording</a> </span><span style="border: 0px; color: #444444; font-family: inherit; font-size: 13.2px; font-style: inherit; margin: 0px; padding: 0px; vertical-align: baseline;"> </span><span style="color: #444444; font-family: "arial" , "verdana" , sans-serif; font-size: 13px;"> </span><span style="background-color: white; color: #444444; font-family: "arial" , "helvetica" , sans-serif; font-size: 13px;"> </span><a href="http://www.ihe.net/uploadedFiles/Content/Participate/Webinars/Webinar_IHE_Pharmacy_DomainUpdate_20150909%20final.pdf" style="color: #9c7dbe; font-family: arial, helvetica, sans-serif; font-size: 13px; text-decoration: none;" title="IHE Pharmacy Webinar 2015 Slides">Slides</a></b></div>
<div>
<br />
<div style="-x-system-font: none; display: block; font-family: Helvetica,Arial,Sans-serif; font-size-adjust: none; font-size: 14px; font-stretch: normal; font-style: normal; font-variant: normal; font-weight: normal; line-height: normal; margin: 12px auto 6px auto;">
<a href="https://www.scribd.com/doc/288108994/Webinar-IHE-Pharmacy-DomainUpdate-20150909-Final" style="text-decoration: underline;" title="View Webinar IHE Pharmacy DomainUpdate 20150909 Final on Scribd">Webinar IHE Pharmacy DomainUpdate 20150909 Final</a></div>
<iframe class="scribd_iframe_embed" data-aspect-ratio="undefined" data-auto-height="false" frameborder="0" height="600" id="doc_65245" scrolling="no" src="https://www.scribd.com/embeds/288108994/content?start_page=1&view_mode=scroll&show_recommendations=true" width="100%"></iframe>
</div>
<div>
<b><br /></b>
<b>Sources</b></div>
<div>
<br /></div>
<div>
<a href="http://www.ihe.net/Webinars/" target="_blank">IHE Webinars</a><br />
<br />
<a href="http://wiki.ihe.net/index.php?title=Pharmacy_Planning_Committee#Webinars" target="_blank">http://wiki.ihe.net/index.php?title=Pharmacy_Planning_Committee#Webinars </a></div>
<div>
<br /></div>
</div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-49993751252500883612015-10-10T21:39:00.002+03:002015-11-23T12:21:07.163+02:00OpenMedicine - for the safety of medicines and patients<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.open-medicine.eu/openmed/" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="24" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEh7H3w4J0tuOnsp1f4PQBnpeq0EOVMi4HkuIY_1UJYmTen1vMSdvPbC5Hy0DROHadkpsIg-dLESP15_kOKKUqUlKkpOwg3zmKPtdm5A4X_r1nYo3gfac5tJoX1XQr5dNb22XlOadQ/s200/openmedicine_tr_dark.png" width="200" /></a></div>
<br />
<b><a href="http://www.open-medicine.eu/openmed/" target="_blank">OpenMedicine</a></b> is an ambitious attempt to support health policy development across <b>European countries and globally</b> in a matter that may affect all of us, since it impacts safety and quality of healthcare in general, and cross-border healthcare in particular.<br />
<br />
To better enable cross-border healthcare delivery, particularly the <b>exchange of ePrescriptions</b> and <b>safe dispensation of prescribed medicinal products</b>, the openMedicine global initiative advances the unique identification of medicinal products (MPs) and thereby <b>patient safety</b> in cross-border settings.<br />
<br />
<br />
<a name='more'></a><br /><br />
Major stakeholders harmonise their respective efforts to deliver<br />
<br />
<ul style="text-align: left;">
<li>a common data model based on and extending standards in use for prescribed medications </li>
<li>an unambiguous vocabulary for the description and identification of medicinal and pharmaceutical products </li>
<li>robust rules to account for and gradually harmonize concepts and practices of therapeutic and economic substitution </li>
<li>an actionable global roadmap to advance post-project implementation realising interoperable and safe eHealth services across local, state, and international borders </li>
<li>coordination of practical solutions and policy recommendations of OpenMedicine with the policy recommendations of the EU/US roadmap process for eHealth cooperation.</li>
</ul>
<br />
The <b><a href="https://ec.europa.eu/digital-agenda/en/news/ehealth-action-plan-2012-2020-innovative-healthcare-21st-century" target="_blank">European Union eHealth Action Plan 2012-2020 - Innovative healthcare for the 21st century</a></b> notes that information and communication technologies (ICT) applied to health (eHealth) can increase the efficiency, safety and quality of health services, and unlock innovation in health markets. At the EU Member State level, much has already been achieved with respect to unleashing the power and benefits from <b><a href="http://www.ehealth-strategies.eu/" target="_blank">eHealth applications</a></b>.<br />
<br />
Delivering efficient cross-border healthcare opens up great opportunities for eHealth applications, but also poses specific challenges, like differences in language, alphabets, culture, etc. The ePrescription pilots implemented as part of the <b><a href="http://www.epsos.eu/" target="_blank">European epSOS project </a></b>identified the “delivery” problem of medicinal products (MPs) mentioned in a prescription as one in urgent need for a solution: it discovered cases where the identification of the medicinal product (MP), which was noted in a prescription from a given country, was impossible for a pharmacist wanting to dispense it in another country. The pharmacist was unable to select from the pharmaceutical products available in that country the product that perfectly matched the prescribed pharmaceutical product. Or, if substitution was permitted, a similar product in line with national regulation.<br />
<br />
<b>Source</b><br />
<br />
<a href="http://www.open-medicine.eu/openmed/" target="_blank">OpenMedicine</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-48105509625135584322015-10-10T20:57:00.002+03:002015-11-23T12:20:48.927+02:00Towards digital health - electronic information for safe use of medicinal products<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="http://www.eesc.europa.eu/?i=portal.en.the-committee" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhWoqOQSyC7o4Rnn_JRgrXmmGWCSVrTwr9YNcVVvP3V7F76dmjq6Y3ODWDaJLqD2HsbZqsrPxClm337x36k-w6bwtzAKw_90HOZNsm0iCc31sRuF5Exu1ECtpvPi3K3U_Odg8KIEA/s1600/EESC.png" /></a></div>
<br />
<b><a href="http://www.eesc.europa.eu/?i=portal.en.the-committee" target="_blank">European Economic and Social Committee</a></b> published on 16 September 2015 an Opinion on:<br />
<br />
<b>"Towards digital health - electronic information for safe use of medicinal products"</b> (own-initiative opinion) [Rapporteur: <b>Renate Heinisch</b>].<br />
<br />
On 22 January 2015, the <b><a href="http://www.eesc.europa.eu/?i=portal.en.the-committee" target="_blank">European Economic and Social Committee</a></b>, acting under Rule 29(2) of its Rules of Procedure, decided to draw up an own-initiative opinion on
Towards digital health – electronic information for safe use of medicinal products
(own-initiative opinion).<br />
<br />
The Section for the Single Market, Production and Consumption, which was responsible for preparing the Committee's work on the subject, adopted its opinion on 14 July 2015.<br />
<br />
<br />
<a name='more'></a><br /><br />
At its 510th plenary session, held on <b>16 and 17 Septembe</b>r (meeting of 16 September), the European Economic and Social Committee adopted the opinion by 212 votes with 6 abstentions:
<br />
<br />
The complete document is <b><a href="http://www.eesc.europa.eu/?&i=portal.en.int-opinions.34664" target="_blank">HERE</a></b>.<br />
<br />
<b>Source</b><br />
<br />
<a href="http://www.eesc.europa.eu/?i=portal.en.the-committee" target="_blank">European Economic and Social Committee (EESC)</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-86088138423619209532015-10-07T18:00:00.002+03:002015-12-06T19:35:32.715+02:00eHealth interoperability: The scene is now clearly shaped<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://ec.europa.eu/digital-agenda/en" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhcyeysppDwSE3h1a_8ugfQKEu008CUlJFrLmbwlC7DI8RzPwDKcAMrfRRDUOe-WHsHmHMYpWAEYani_M86GKI3Dmnvy2ONufAD54TkwI6XpDUfSLGO5KhpZIg3Kr8FEF8fCvDz5A/s1600/logo_en.gif" /></a></div>
<br />
<span style="background-color: #fff6ea; color: #333333; font-family: "verdana" , "arial" , "helvetica" , "dejavu sans" , sans-serif; font-size: 13px;">Last July, the European Commission recognised 27 profiles and standards for healthcare systems to be developed through public procurement. This is a step forward for reaching the European Digital Single Market in eHealth.</span><br />
<span style="background-color: #fff6ea; color: #333333; font-family: "verdana" , "arial" , "helvetica" , "dejavu sans" , sans-serif; font-size: 13px;"><br /></span>
<br />
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
Many countries in Europe are developing eHealth strategies in order to offer their citizens a better quality of care within a financially sustainable healthcare system. The population is ageing and has specific needs, whilst mobility is increasing in Europe.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
These challenges are addressed with the development of new technologies that support the necessary and required connection of healthcare ICT used in healthcare organisations and at regional, national and cross-border levels.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
In this respect, a common <a href="https://ec.europa.eu/digital-agenda/en/news/ehealth-interoperability-framework-study-0" style="box-sizing: border-box; color: #0065a2;">European Interoperability Framework</a> was defined and published by the European Commission in 2012. It describes an initial set of use cases and a selection of 27 Profiles and Standards.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
After an evaluation process and consultation of the European multi-stakeholder platform for ICT, the European Commission has now <a href="http://www.europarl.europa.eu/document/activities/cont/201310/20131029ATT73586/20131029ATT73586EN.pdf" style="box-sizing: border-box; color: #0065a2;">identified</a> and recognised these 27 so called <a href="http://www.ihe-europe.net/" style="box-sizing: border-box; color: #0065a2;">IHE</a> ("Integrating the Healthcare Enterprise") Profiles for procurement.<br />
<br />
<br />
<a name='more'></a></div>
<h3 style="border-bottom-color: rgb(238, 240, 245); border-bottom-style: solid; border-bottom-width: 1px; box-sizing: border-box; color: #222222; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 16px; font-weight: 500; line-height: 1.1; margin-bottom: 10px; margin-top: 32px; padding-bottom: 7px;">
Exchanging medical data</h3>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
What are IHE Profiles? They are an international specification dedicated to the healthcare domain for exchanging medical data among healthcare systems. Most of these profiles are used in many projects in Europe or around the world and allow harmonisation amongst Member States for achieving the Digital Single Market.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
The profiles are also used in the specifications of the <a href="http://www.epsos.eu/" style="box-sizing: border-box; color: #0065a2;">epSOS</a> project for exchanging Patient Summaries and ePrescriptions for patients travelling across Europe.</div>
<h3 style="border-bottom-color: rgb(238, 240, 245); border-bottom-style: solid; border-bottom-width: 1px; box-sizing: border-box; color: #222222; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 16px; font-weight: 500; line-height: 1.1; margin-bottom: 10px; margin-top: 32px; padding-bottom: 7px;">
This will accelerate the deployment of eHealth</h3>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
For many European countries that have already been using such a set of profiles in correspondence with the eHealth Interoperability Framework, this recognition will accelerate the deployment of eHealth and will support their eHealth strategies of the last couple of years.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
Experts working on eHealth projects should build or extend their interoperability specifications by referencing and building upon these profiles, and select those that meet their interoperability use cases. Such shared specifications will not only reduce the project specification efforts, but also facilitate implementation by vendors through software and significantly reduce the testing efforts both for the software developers and the eHealth projects.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
These test tools are <a href="http://wiki.ihe.net/index.php?title=IHE_Test_Tool_Information" style="box-sizing: border-box; color: #0065a2;">available</a> and support developers for implementing the 27 IHE profiles in their products or projects.</div>
<h3 style="border-bottom-color: rgb(238, 240, 245); border-bottom-style: solid; border-bottom-width: 1px; box-sizing: border-box; color: #222222; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 16px; font-weight: 500; line-height: 1.1; margin-bottom: 10px; margin-top: 32px; padding-bottom: 7px;">
Connectathon</h3>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
In addition, the yearly European <a href="http://connectathon2014.ihe-europe.net/" style="box-sizing: border-box; color: #0065a2;">Connectathon</a> encourages vendors and projects to test their products against their peers, to share their experiences and benefit from the knowledge imparted by international standard experts. The next annual Connectathon will take place on 11-15 April 2016 and will be hosted by Germany.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
The scene is now clearly shaped: Interoperability knowledge is sufficiently shared in Europe amongst the workforce from vendors, national or regional centers of competences or care providers. This will ensure large scale deployment of eHealth in Europe with the integration of innovative solutions such as mobiles and homecare devices.</div>
<div style="box-sizing: border-box; color: #555555; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; margin-bottom: 10px;">
<em style="box-sizing: border-box;"><a href="https://ec.europa.eu/digital-agenda/en/users/nmildepe" style="box-sizing: border-box; color: #0065a2;">Peter Mildenberger</a> is Professor of Radiology at the Johannes Gutenberg University Mainz in Germany. He is also co-chair of <a href="http://www.ihe-europe.net/" style="box-sizing: border-box; color: #0065a2;" target="_blank">IHE-Europe</a>, a non-profit association dedicated to interoperability in health information technology.</em></div>
<br />
<b>Source</b><br />
<b><br /></b>
<span style="background-color: white; color: #777777; font-family: "verdana" , "arial" , "helvetica" , "dejavu sans" , sans-serif; font-size: 13px;">Author: </span><a class="" href="https://ec.europa.eu/digital-agenda/en/users/nmildepe" style="box-sizing: border-box; color: #0065a2; display: inline-block; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px; padding-left: 21px; position: relative;">Peter Mildenberger</a><span style="background-color: white; color: #777777; font-family: "verdana" , "arial" , "helvetica" , "dejavu sans" , sans-serif; font-size: 13px;">, published in </span><a class="" href="https://ec.europa.eu/digital-agenda/en/blog_home" style="box-sizing: border-box; color: #0065a2; font-family: Verdana, Arial, Helvetica, 'DejaVu Sans', sans-serif; font-size: 13px;">DAE blog</a><span style="background-color: white; color: #777777; font-family: "verdana" , "arial" , "helvetica" , "dejavu sans" , sans-serif; font-size: 13px;"> on 06/10/2015</span><br />
<br />
<a href="https://ec.europa.eu/digital-agenda/en" target="_blank">DIGITAL AGENDA FOR EUROPE</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.comtag:blogger.com,1999:blog-9356552.post-53205023595682489142015-09-22T18:40:00.000+03:002015-12-06T19:36:23.955+02:00EAHP Academy Seminar 2015: From medicines reconciliation to medicines optimisation<div dir="ltr" style="text-align: left;" trbidi="on">
<div class="separator" style="clear: both; text-align: center;">
<a href="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhmIFJLUD4j1PnSkXOaUhHrNzTrczUQgB47BTrgvDWiU6O3u6VvwjIMB4JqwJVscaB6ZZKH4R_ySUDj91lBw54UugkoM-QYFpMQDg87EWZiCr8O2pB-vL-KwgjQm8_Bf1Hyr7Y-sw/s1600/euMonitopr+logo.jpg" imageanchor="1" style="clear: left; float: left; margin-bottom: 1em; margin-right: 1em;"><img border="0" height="115" src="https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhmIFJLUD4j1PnSkXOaUhHrNzTrczUQgB47BTrgvDWiU6O3u6VvwjIMB4JqwJVscaB6ZZKH4R_ySUDj91lBw54UugkoM-QYFpMQDg87EWZiCr8O2pB-vL-KwgjQm8_Bf1Hyr7Y-sw/s200/euMonitopr+logo.jpg" width="200" /></a></div>
<br />
From 11th to 12th September 2015, over <b>50 hospital pharmacists from 30 countries</b> gathered in <b>Zagreb, Croatia</b> for a focused weekend of education development on the theme<br />
<br />
"<b><span style="color: #0c343d;">From medicines reconciliation to medicines optimisation</span></b>".<br />
<br />
Experts speakers from across Europe addressed diverse aspects of medicines reconciliation services, including:<br />
<br />
<ul style="text-align: left;">
<li>medicines reconciliation on admission; </li>
<li>lessons learnt for successful implementation of medicines reconciliation; </li>
<li>integrated medicines management with a focus on the discharge process; and, </li>
<li>structured patient interviews on error incidence and severity. </li>
</ul>
<br />
<a name='more'></a><br /><br />
The Academy Seminar is an annual educational event facilitated and provided by the <b><a href="http://www.eahp.eu/" target="_blank">European Association of Hospital Pharmacists</a></b> to its member organisations.
The aim of the Academy is to foster research and educational activities to allow hospital pharmacists from all European countries to develop their activities in a general setting of public health in their country or across the continent. Medicines reconciliation forms an important part of the vision for the hospital pharmacy profession expressed through the <a href="http://ejhp.bmj.com/content/21/5/256.full.pdf+html" target="_blank">44 European Statements of Hospital Pharmacy</a>.<br />
<br />
<b>Presentations from the event are available online <a href="http://www.eahp.eu/events/academy/academy-seminar-2015-zagreb-croatia/seminar-presentations" target="_blank">here</a></b>.<br />
<br />
More information about<b> EAHP's Academy Seminar programme</b> is available <b><a href="http://www.eahp.eu/events/academy/EAHP-Academy-Seminars" target="_blank">here</a></b>.<br />
<br />
<b>Source</b><br />
<br />
<a href="http://www.eahp.eu/news/EU-monitor/" target="_blank">EAHP EU-monitor</a></div>
tzileonhttp://www.blogger.com/profile/15760020618045351691noreply@blogger.com